{"id":"F2026L00396","name":"National Health (Pharmaceutical Benefits—Early Supply) Specification 2026","slug":"national-health-pharmaceutical-benefits-early-supply-specification-2026","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":443235,"registerId":"F2026L00396-fast-fetch-1775958122443","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"2","sectionType":"section","heading":"Commencement","content":"2  Commencement\n\n (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.\n\n \n\n- Commencement information\n- Column 1 Column 2 Column 3\n- Provisions Commencement Date/Details\n- 1. The whole of this instrument 1 April 2026 1 April 2026.\n\nNote: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.\n\n (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.\n\n","sortOrder":0},{"sectionNumber":"3","sectionType":"section","heading":"Authority","content":"3  Authority\n\n  This instrument is made under subsection 84AAA(2) of the National Health Act 1953.\n\n","sortOrder":1},{"sectionNumber":"4","sectionType":"section","heading":"Schedule 3","content":"4  Schedule 3\n\nEach instrument that is specified in Schedule 3 to this instrument is amended or repealed as set out in the applicable items in the Schedule, and any other item in that Schedule has effect according to its terms.\n\n","sortOrder":2},{"sectionNumber":"5","sectionType":"section","heading":"Definitions","content":"5  Definitions\n\n (1) In this instrument:\n\nAct means the National Health Act 1953.\n\ndetermined maximum quantity or number of units, for a pharmaceutical item in a pharmaceutical benefit, means a quantity or number of units determined under paragraph 85A(2)(a) of the Act as the maximum quantity or number of units of the pharmaceutical item that may, in one prescription, be directed to be supplied on any one occasion determined.\n\nNote: A maximum quantity or number of units can be determined in relation to prescriptions directing the supply of the pharmaceutical item for all purposes, or for particular purposes: see paragraph 85A(2)(a) of the Act.\n\ndetermined maximum number of repeats, for a pharmaceutical benefit, means the number determined under paragraph 85A(2)(b) of the Act as a maximum number of occasions on which the supply of the pharmaceutical benefit may, in one prescription, be directed to be repeated.\n\nNote: A maximum number of repeats can be determined in relation to prescriptions directing the supply of the pharmaceutical benefit for all purposes, or for particular purposes: see paragraph 85A(2)(b) of the Act.\n\ng means gram.\n\nI.U. means international unit.\n\nlisted drug has the meaning given by section 84 of the Act.\n\nmg means milligram.\n\nmL means millilitre.\n\npharmaceutical benefit has the meaning given by section 84 of the Act.\n\npharmaceutical item has the meaning given by section 84AB of the Act.\n\nprescriber bag provisions has the meaning given by section 84 of the Act.\n\npurposes code has the same meaning as in the National Health (Listing of Pharmaceutical Benefits) Instrument 2024.\n\nrelevant previous supply, for a pharmaceutical benefit, means the most recent previous supply to a person of:\n\n (a) the same pharmaceutical benefit; or\n\n (b) another pharmaceutical benefit that has the same pharmaceutical item as the pharmaceutical benefit; or\n\n (c) another pharmaceutical benefit that is Schedule equivalent to the pharmaceutical benefit.\n\nrelevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Schedule 4 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for a purposes code specified in Schedule 1 of that instrument for the pharmaceutical benefit, that includes the phrase “The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient”.\n\nSchedule equivalent has the meaning given by section 84AJ of the Act.\n\n (2) A reference in this instrument to supply on the basis of a prescription includes reference to supply on the basis of a repeat authorisation or deferred supply authorisation.\n\n (3) Unless the contrary intention appears, a reference in this instrument to Schedule 1 or Schedule 2 is taken to be a reference to Schedule 1 to this instrument or Schedule 2 to this instrument, respectively.\n\n","sortOrder":3},{"sectionNumber":"6","sectionType":"section","heading":"Specification of pharmaceutical items","content":"6  Specification of pharmaceutical items\n\n (1) A pharmaceutical item in a pharmaceutical benefit is specified for paragraph 84AAA(1)(a) of the Act if subsection (2) or (3) of this section applies in relation to the pharmaceutical item.\n\n (2) This subsection applies in relation to the pharmaceutical item if:\n\n (a) the listed drug and the form of that listed drug in the pharmaceutical item are mentioned in an item in the table in Schedule 1; and\n\n (b) all the circumstances specified in section 7 exist in relation to a pharmaceutical benefit that has that listed drug in that form.\n\n (3) This subsection applies in relation to the pharmaceutical item if:\n\n (a) the listed drug and the form of that listed drug in the pharmaceutical item are mentioned in an item in the table in Schedule 2; and\n\n (b) all the circumstances specified in section 8 exist in relation to a pharmaceutical benefit that has that listed drug in that form.\n\n","sortOrder":4},{"sectionNumber":"7","sectionType":"section","heading":"Circumstances relating to specification of pharmaceutical items in Schedule 1","content":"7  Circumstances relating to specification of pharmaceutical items in Schedule 1\n\n  For paragraph 6(2)(b), the circumstances in relation to a pharmaceutical benefit are:\n\n (a) the supply of the benefit is made:\n\n (i) on the basis of a prescription; or\n\n (ii) to a person by an approved pharmacist under subsection 89A(1) of the Act; and\n\n (b) if the pharmaceutical benefit is supplied as referred to in subparagraph (a)(i)—the prescription must have been written:\n\n (i) for a purpose for which the maximum quantity or number of units specified in the column headed ‘Maximum quantity or number of units’ in an item in Schedule 1 for the pharmaceutical item was determined under paragraph 85A(2)(a) of the Act; and\n\n (ii) for a purpose for which the maximum number of repeats specified in the column headed ‘Maximum number of repeats’ specified in the same table item in Schedule 1 for the pharmaceutical benefit was determined under paragraph 85A(2)(b) of the Act; and\n\n (c) if the pharmaceutical benefit is supplied as referred to in subparagraph (a)(ii)—the quantity or number of units of the pharmaceutical benefit supplied to the person must be a quantity or number of units specified for the pharmaceutical item in the pharmaceutical benefit in an item in Schedule 1; and\n\n (d) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 1 for the benefit.\n\n","sortOrder":5},{"sectionNumber":"8","sectionType":"section","heading":"Circumstances relating to specification of pharmaceutical items in Schedule 2","content":"8  Circumstances relating to specification of pharmaceutical items in Schedule 2\n\n  For paragraph 6(3)(b), the circumstances in relation to a pharmaceutical benefit are:\n\n (a) the supply of the benefit is made on the basis of a prescription; and\n\n (b) the supply was not made under subsection 89A(1) of the Act; and\n\n (c) the prescription must have been written:\n\n (i) for a purpose for which the maximum quantity or number of units specified in the column headed ‘Maximum quantity or number of units’ in an item in Schedule 2 for the pharmaceutical item was determined under paragraph 85A(2)(a) of the Act; and\n\n (ii) for a purpose for which the maximum number of repeats specified in the column headed ‘Maximum number of repeats’ specified in the same table item in Schedule 2 for the pharmaceutical benefit was determined under paragraph 85A(2)(b) of the Act; and\n\n (d) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 2 for the benefit.\n\n","sortOrder":6},{"sectionNumber":"9","sectionType":"section","heading":"Specification of period relating to a pharmaceutical benefit","content":"9  Specification of period relating to a pharmaceutical benefit\n\n (1) This section is made for paragraph 84AAA(1)(b) of the Act.\n\n (2) For a pharmaceutical benefit that has a listed drug mentioned in an item in Schedule 1 in the form mentioned in that item, and the circumstances identified for section 7 apply, the period specified is the number of days mentioned under the heading ‘Period (days)’ for the item in Schedule 1.\n\n (3) For a pharmaceutical benefit that has a listed drug mentioned in an item in Schedule 2 in the form mentioned in that item, and the circumstances identified for section 8 apply:\n\n (a) if:\n\n (i) the relevant previous supply to the person was made on the basis of a prescription; and\n\n (ii) the quantity or number of units of the pharmaceutical benefit directed to be supplied on any one occasion in the prescription was directed for a relevant purpose for the previously supplied pharmaceutical benefit:\n\n  the period specified is the number of days mentioned under the heading ‘Period (days)’ for the item in Schedule 2; and\n\n (b) in any other case—the period specified is 20 days.\n\n (4) Despite subsections (2) and (3), if the relevant previous supply of the pharmaceutical benefit was made under a prescriber bag provision, the period specified is zero days.  \n\n","sortOrder":7},{"sectionNumber":"Sch 1","sectionType":"schedule","heading":"Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply","content":"Schedule 1—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply\n\n \n\n- Listed drug Form Period(days) Circumstances:\n- Maximum quantity or number of units Maximum number of repeats Other circumstances (if any)\n- Abatacept Injection 125 mg in 1 mL single dose autoinjector 20 4 5\n- Abatacept Injection 125 mg in 1 mL single dose pre-filled syringe 20 4 5\n- Abemaciclib Tablet 50 mg 20 56 5\n- Abemaciclib Tablet 100 mg 20 56 5\n- Abemaciclib Tablet 150 mg 20 56 5\n- Abiraterone Tablet containing abiraterone acetate 250 mg 20 120 2\n- Abiraterone Tablet containing abiraterone acetate 500 mg 20 60 2\n- Acalabrutinib Tablet 100 mg 20 56 5\n- Acalabrutinib Tablet 100 mg 20 56 6\n- Aciclovir Tablet 200 mg 20 90 5\n- Aclidinium Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses 20 1 5\n- Aclidinium with formoterol Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses 20 1 5\n- Adalimumab Injection 20 mg in 0.2 mL pre-filled syringe 20 2 0\n- Adalimumab Injection 20 mg in 0.2 mL pre-filled syringe 20 2 3\n- Adalimumab Injection 20 mg in 0.2 mL pre-filled syringe 20 2 5\n- Adalimumab Injection 20 mg in 0.2 mL pre-filled syringe 20 2 6\n- Adalimumab Injection 20 mg in 0.4 mL pre-filled syringe 20 2 0\n- Adalimumab Injection 20 mg in 0.4 mL pre-filled syringe 20 2 3\n- Adalimumab Injection 20 mg in 0.4 mL pre-filled syringe 20 2 5\n- Adalimumab Injection 20 mg in 0.4 mL pre-filled syringe 20 2 6\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 2 0\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 2 2\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 2 5\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 2 6\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 4 5\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled pen 20 6 0\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe 20 2 0\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe 20 2 2\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe 20 2 5\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe 20 2 6\n- Adalimumab Injection 40 mg in 0.4 mL pre-filled syringe 20 6 0\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 2 0\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 2 2\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 2 5\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 2 6\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 4 5\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled pen 20 6 0\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe 20 2 0\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe 20 2 2\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe 20 2 5\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe 20 2 6\n- Adalimumab Injection 40 mg in 0.8 mL pre-filled syringe 20 6 0\n- Adalimumab Injection 80 mg in 0.8 mL pre-filled pen 20 2 5\n- Adalimumab Injection 80 mg in 0.8 mL pre-filled pen 20 3 0\n- Adalimumab Injection 80 mg in 0.8 mL pre-filled syringe 20 2 5\n- Adalimumab Injection 80 mg in 0.8 mL pre-filled syringe 20 3 0\n- Alendronic acid Tablet 70 mg (as alendronate sodium) 20 4 5\n- Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol 20 4 5\n- Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol 20 4 5\n- Allopurinol Tablet 100 mg 20 200 2\n- Allopurinol Tablet 300 mg 20 60 2\n- Alogliptin Tablet 6.25 mg (as benzoate) 20 28 5\n- Alogliptin Tablet 12.5 mg (as benzoate) 20 28 5\n- Alogliptin Tablet 25 mg (as benzoate) 20 28 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride 20 56 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride 20 56 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride 20 56 5\n- Amantadine Capsule containing amantadine hydrochloride 100 mg 20 100 5\n- Amifampridine Tablet 10 mg 20 200 5\n- Amlodipine Tablet 5 mg (as besilate) 20 30 5\n- Amlodipine Tablet 10 mg (as besilate) 20 30 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) 20 30 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-80 mg 20 28 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-160 mg 20 28 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-320 mg 20 28 5\n- Amlodipine with valsartan Tablet 10 mg (as besilate)-160 mg 20 28 5\n- Amlodipine with valsartan Tablet 10 mg (as besilate)-320 mg 20 28 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 5 mg (as besilate)-160 mg-12.5 mg 20 28 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 5 mg (as besilate)-160 mg-25 mg 20 28 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-160 mg-12.5 mg 20 28 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-160 mg-25 mg 20 28 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-320 mg-25 mg 20 28 5\n- Anastrozole Tablet 1 mg 20 30 5\n- Apalutamide Tablet 60 mg 20 120 5\n- Apixaban Tablet 2.5 mg 20 60 0\n- Apixaban Tablet 2.5 mg 20 60 5\n- Apixaban Tablet 5 mg 20 28 0\n- Apixaban Tablet 5 mg 20 60 5\n- Armodafinil Tablet 50 mg 20 60 5\n- Armodafinil Tablet 150 mg 20 30 5\n- Armodafinil Tablet 250 mg 20 30 5\n- Asciminib Tablet 20 mg 20 60 5\n- Asciminib Tablet 40 mg 20 60 5\n- Asciminib Tablet 40 mg 20 300 5\n- Aspirin Tablet 100 mg 20 112 1\n- Atazanavir with cobicistat Tablet containing 300 mg atazanavir and 150 mg cobicistat 20 60 5\n- Atenolol Oral solution 50 mg in 10 mL, 300 mL 20 1 5\n- Atenolol Tablet 50 mg 20 30 5\n- Atomoxetine Capsule 10 mg (as hydrochloride) 20 56 5\n- Atomoxetine Capsule 18 mg (as hydrochloride) 20 56 5\n- Atomoxetine Capsule 25 mg (as hydrochloride) 20 56 5\n- Atomoxetine Capsule 40 mg (as hydrochloride) 20 56 5\n- Atomoxetine Capsule 60 mg (as hydrochloride) 20 56 5\n- Atomoxetine Capsule 80 mg (as hydrochloride) 20 28 5\n- Atomoxetine Capsule 100 mg (as hydrochloride) 20 28 5\n- Atorvastatin Tablet 10 mg (as calcium) 20 30 5\n- Atorvastatin Tablet 20 mg (as calcium) 20 30 5\n- Atorvastatin Tablet 40 mg (as calcium) 20 30 5\n- Atorvastatin Tablet 80 mg (as calcium) 20 30 5\n- Auranofin Capsule 3 mg 20 60 5\n- Auranofin Tablet 3 mg 20 60 5\n- Azacitidine Tablet 200 mg 20 14 2\n- Azacitidine Tablet 300 mg 20 14 2\n- Azacitidine Tablet 300 mg 20 21 1\n- Azathioprine Tablet 25 mg 20 100 5\n- Azathioprine Tablet 50 mg 20 100 5\n- Baclofen Tablet 10 mg 20 100 5\n- Baclofen Tablet 25 mg 20 100 5\n- Balsalazide Capsule containing balsalazide sodium 750 mg 20 280 5\n- Baricitinib Tablet 2 mg 20 28 5\n- Baricitinib Tablet 4 mg 20 28 5\n- Beclometasone with formoterol and glycopyrronium Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses 20 1 5\n- Beclometasone with formoterol and glycopyrronium Pressurised inhalation containing beclometasone dipropionate 200 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses 20 1 5\n- Betaine Oral powder 180 g 20 1 5\n- Betamethasone Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL 20 5 0\n- Bicalutamide Tablet 50 mg 20 28 5\n- Bictegravir with emtricitabine with tenofovir alafenamide Tablet containing bictegravir 50 mg with emtricitabine 200 mg with tenofovir alafenamide 25 mg 20 60 5\n- Bimekizumab Injection 160 mg in 1 mL single use pre-filled pen 20 2 1\n- Bimekizumab Injection 160 mg in 1 mL single use pre-filled pen 20 2 2\n- Bimekizumab Injection 160 mg in 1 mL single use pre-filled pen 20 2 4\n- Bimekizumab Injection 160 mg in 1 mL single use pre-filled pen 20 2 5\n- Bimekizumab Injection 160 mg in 1 mL single use pre-filled pen 20 4 3\n- Bimekizumab Injection 320 mg in 2 mL single use pre-filled pen 20 1 2\n- Bimekizumab Injection 320 mg in 2 mL single use pre-filled pen 20 1 4\n- Bimekizumab Injection 320 mg in 2 mL single use pre-filled pen 20 1 5\n- Bimekizumab Injection 320 mg in 2 mL single use pre-filled pen 20 2 3\n- Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg 20 28 5\n- Bisoprolol Tablet containing bisoprolol fumarate 5 mg 20 28 5\n- Bisoprolol Tablet containing bisoprolol fumarate 10 mg 20 28 5\n- Brexpiprazole Tablet 500 micrograms 20 30 0\n- Brexpiprazole Tablet 1 mg 20 30 0\n- Brexpiprazole Tablet 2 mg 20 30 5\n- Brexpiprazole Tablet 3 mg 20 30 5\n- Brexpiprazole Tablet 4 mg 20 30 5\n- Brivaracetam Oral solution 10 mg per mL, 300 mL 20 1 5\n- Brivaracetam Tablet 25 mg 20 56 5\n- Brivaracetam Tablet 50 mg 20 56 5\n- Brivaracetam Tablet 75 mg 20 56 5\n- Brivaracetam Tablet 100 mg 20 56 5\n- Budesonide with glycopyrronium and formoterol Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses 20 1 5\n- Buprenorphine Injection (modified release) 8 mg in 0.16 mL pre-filled syringe 20 4 5\n- Buprenorphine Injection (modified release) 16 mg in 0.32 mL pre-filled syringe 20 4 5\n- Buprenorphine Injection (modified release) 24 mg in 0.48 mL pre-filled syringe 20 4 5\n- Buprenorphine Injection (modified release) 32 mg in 0.64 mL pre-filled syringe 20 4 5\n- Buprenorphine Injection (modified release) 64 mg in 0.18 mL pre-filled syringe 20 1 5\n- Buprenorphine Injection (modified release) 96 mg in 0.27 mL pre-filled syringe 20 1 5\n- Buprenorphine Injection (modified release) 100 mg in 0.5 mL pre-filled syringe 20 1 5\n- Buprenorphine Injection (modified release) 128 mg in 0.36 mL pre-filled syringe 20 1 5\n- Buprenorphine Injection (modified release) 160 mg in 0.45 mL pre-filled syringe 20 1 5\n- Buprenorphine Injection (modified release) 300 mg in 1.5 mL pre-filled syringe 20 1 5\n- Buprenorphine Tablet (sublingual) 400 micrograms (as hydrochloride) 20 28 5\n- Buprenorphine Tablet (sublingual) 2 mg (as hydrochloride) 20 84 5\n- Buprenorphine Tablet (sublingual) 8 mg (as hydrochloride) 20 112 5\n- Buprenorphine with naloxone Film (soluble) 2 mg (as hydrochloride)-0.5 mg (as hydrochloride) 20 84 5\n- Buprenorphine with naloxone Film (soluble) 8 mg (as hydrochloride)-2 mg (as hydrochloride) 20 112 5\n- Bupropion Tablet containing bupropion hydrochloride 150 mg (sustained release) 20 30 0\n- Bupropion Tablet containing bupropion hydrochloride 150 mg (sustained release) 20 90 0\n- Cabergoline Tablet 1 mg 20 30 5\n- Cabergoline Tablet 2 mg 20 30 5\n- Cabozantinib Tablet 20 mg 20 30 2\n- Cabozantinib Tablet 20 mg 20 30 5\n- Cabozantinib Tablet 40 mg 20 30 2\n- Cabozantinib Tablet 40 mg 20 30 5\n- Cabozantinib Tablet 60 mg 20 30 2\n- Cabozantinib Tablet 60 mg 20 30 5\n- Calcitonin salmon Injection 100 I.U. in 1 mL 20 15 5\n- Calcitriol Capsule 0.25 microgram 20 100 3\n- Calcium Tablet 600 mg (as carbonate) 20 240 1\n- Candesartan Tablet containing candesartan cilexetil 4 mg 20 30 5\n- Candesartan Tablet containing candesartan cilexetil 8 mg 20 30 5\n- Candesartan Tablet containing candesartan cilexetil 16 mg 20 30 5\n- Candesartan Tablet containing candesartan cilexetil 32 mg 20 30 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg 20 30 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg 20 30 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg 20 30 5\n- Carbamazepine Tablet 100 mg 20 200 0\n- Carbamazepine Tablet 100 mg 20 200 2\n- Carbamazepine Tablet 200 mg 20 200 0\n- Carbamazepine Tablet 200 mg 20 200 2\n- Carbamazepine Tablet 200 mg (controlled release) 20 200 0\n- Carbamazepine Tablet 200 mg (controlled release) 20 200 2\n- Carbamazepine Tablet 400 mg (controlled release) 20 200 0\n- Carbamazepine Tablet 400 mg (controlled release) 20 200 2\n- Carvedilol Tablet 6.25 mg 20 60 5\n- Carvedilol Tablet 12.5 mg 20 60 5\n- Carvedilol Tablet 25 mg 20 60 5\n- Certolizumab pegol Injection 200 mg in 1 mL single use pre-filled syringe 20 2 5\n- Certolizumab pegol Solution for injection 200 mg in 1 mL pre-filled pen 20 2 5\n- Citalopram Tablet 20 mg (as hydrobromide) 20 28 5\n- Citalopram Tablet 40 mg (as hydrobromide) 20 28 5\n- Clonazepam Tablet 2 mg 20 200 2\n- Clonazepam Tablet 500 micrograms 20 200 2\n- Clonidine Tablet containing clonidine hydrochloride 100 micrograms 20 100 5\n- Clonidine Tablet containing clonidine hydrochloride 150 micrograms 20 100 5\n- Clopidogrel Tablet 75 mg (as besilate) 20 28 5\n- Clopidogrel Tablet 75 mg (as bisulfate) (Aurobindo, USA) (S19A) 20 28 5\n- Clopidogrel Tablet 75 mg (as bisulfate) (Novadoz, USA) (S19A) 20 28 5\n- Clopidogrel Tablet 75 mg (as hydrogen sulfate) 20 28 5\n- Clopidogrel Tablet 75 mg (as hydrogen sulfate) (S19A) 20 28 5\n- Clopidogrel with aspirin Tablet 75 mg (as hydrogen sulfate)-100 mg 20 30 5\n- Dabigatran etexilate Capsule 75 mg (as mesilate) 20 60 0\n- Dabigatran etexilate Capsule 110 mg (as mesilate) 20 60 0\n- Dabigatran etexilate Capsule 110 mg (as mesilate) 20 60 5\n- Dabigatran etexilate Capsule 150 mg (as mesilate) 20 60 5\n- Dabrafenib Capsule 50 mg (as mesilate) 20 120 5\n- Dabrafenib Capsule 75 mg (as mesilate) 20 120 5\n- Dapagliflozin Tablet 10 mg (as propanediol monohydrate) 20 28 5\n- Dapagliflozin with metformin Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride 20 56 5\n- Dapagliflozin with metformin Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride 20 28 5\n- Dapagliflozin with metformin Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride 20 28 5\n- Dapagliflozin with sitagliptin Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate) 20 28 5\n- Dapsone Tablet 25 mg 20 100 1\n- Dapsone Tablet 50 mg 20 100 1\n- Dapsone Tablet 100 mg 20 100 1\n- Darolutamide Tablet 300 mg 20 112 5\n- Darunavir with cobicistat, emtricitabine and tenofovir alafenamide Tablet containing darunavir 800 mg with cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg 20 60 5\n- Dasatinib Tablet 20 mg 20 60 2\n- Dasatinib Tablet 20 mg 20 60 5\n- Dasatinib Tablet 50 mg 20 60 2\n- Dasatinib Tablet 50 mg 20 60 5\n- Dasatinib Tablet 70 mg 20 60 2\n- Dasatinib Tablet 70 mg 20 60 5\n- Dasatinib Tablet 100 mg 20 30 2\n- Dasatinib Tablet 100 mg 20 30 5\n- Decitabine with cedazuridine Tablet containing decitabine 35 mg with cedazuridine 100 mg 20 5 2\n- Decitabine with cedazuridine Tablet containing decitabine 35 mg with cedazuridine 100 mg 20 5 5\n- Degarelix Powder for injection 80 mg (as acetate), injection set 20 1 5\n- Degarelix Powder for injection 120 mg (as acetate), 2, injection set 20 1 0\n- Denosumab Injection 60 mg in 1 mL pre-filled syringe 20 1 0\n- Desmopressin Tablet containing desmopressin acetate 200 micrograms 20 30 5\n- Desmopressin Tablet containing desmopressin acetate 200 micrograms 20 90 5\n- Desmopressin Tablet (sublingual) 120 micrograms (as acetate) 20 30 5\n- Desmopressin Tablet (sublingual) 240 micrograms (as acetate) 20 30 5\n- Desmopressin Wafer 120 micrograms (as acetate) 20 30 5\n- Desmopressin Wafer 240 micrograms (as acetate) 20 30 5\n- Desvenlafaxine Tablet (extended release) 50 mg (as succinate) 20 28 5\n- Desvenlafaxine Tablet (extended release) 100 mg (as succinate) 20 28 5\n- Desvenlafaxine Tablet (modified release) 50 mg 20 28 5\n- Desvenlafaxine Tablet (modified release) 50 mg (as benzoate) 20 28 5\n- Desvenlafaxine Tablet (modified release) 100 mg 20 28 5\n- Desvenlafaxine Tablet (modified release) 100 mg (as benzoate) 20 28 5\n- Deucravacitinib Tablet 6 mg 20 28 5\n- Dienogest Tablet 2 mg 20 28 5\n- Digoxin Tablet 62.5 micrograms 20 200 1\n- Digoxin Tablet 250 micrograms 20 100 1\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg 20 30 5\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg 20 30 5\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg 20 30 5\n- Diltiazem Tablet containing diltiazem hydrochloride 60 mg 20 90 5\n- Dimethyl fumarate Capsule (modified release) 240 mg 20 56 5\n- Diroximel fumarate Capsule (enteric) 231 mg 20 120 5\n- Dolutegravir with lamivudine Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg 20 60 5\n- Dolutegravir with rilpivirine Tablet containing dolutegravir 50 mg (as sodium) with rilpivirine 25 mg (as hydrochloride) 20 60 5\n- Donepezil Tablet containing donepezil hydrochloride 5 mg 20 28 5\n- Donepezil Tablet containing donepezil hydrochloride 10 mg 20 28 5\n- Drospirenone Pack containing 24 tablets 4 mg and 4 inert tablets 20 4 2\n- Drospirenone Pack containing 24 tablets 4 mg and 4 inert tablets, 3 20 1 3\n- Drospirenone with ethinylestradiol Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets 20 3 3\n- Drospirenone with ethinylestradiol Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol and 4 inert tablets 20 3 3\n- Drospirenone with ethinylestradiol Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol (as betadex clathrate) and 4 inert tablets 20 3 3\n- Dulaglutide Injection 1.5 mg in 0.5 mL single dose pre-filled pen 20 4 5\n- Duloxetine Capsule 60 mg (as hydrochloride) 20 28 5\n- Dupilumab Injection 200 mg in 1.14 mL single dose pre-filled pen 20 2 5\n- Dupilumab Injection 200 mg in 1.14 mL single dose pre-filled syringe 20 2 5\n- Dupilumab Injection 300 mg in 2 mL single dose pre-filled pen 20 2 5\n- Dupilumab Injection 300 mg in 2 mL single dose pre-filled syringe 20 2 5\n- Dutasteride Capsule 500 micrograms 20 30 5\n- Dutasteride with tamsulosin Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms 20 30 5\n- Elafibranor Tablet 80 mg 20 30 5\n- Elranatamab Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL) 20 1 1\n- Elranatamab Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL) 20 1 5\n- Empagliflozin Tablet 10 mg 20 30 5\n- Empagliflozin Tablet 25 mg 20 30 5\n- Empagliflozin with linagliptin Tablet containing 10 mg empagliflozin with 5 mg linagliptin 20 30 5\n- Empagliflozin with linagliptin Tablet containing 25 mg empagliflozin with 5 mg linagliptin 20 30 5\n- Empagliflozin with metformin Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride 20 60 5\n- Empagliflozin with metformin Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride 20 60 5\n- Empagliflozin with metformin Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride 20 60 5\n- Empagliflozin with metformin Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride 20 60 5\n- Enalapril Tablet containing enalapril maleate 5 mg 20 30 5\n- Enalapril Tablet containing enalapril maleate 10 mg 20 30 5\n- Enalapril Tablet containing enalapril maleate 20 mg 20 30 5\n- Enalapril with hydrochlorothiazide Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg 20 30 5\n- Entacapone Tablet 200 mg 20 200 4\n- Enzalutamide Capsule 40 mg 20 112 2\n- Enzalutamide Capsule 40 mg 20 112 5\n- Eplerenone Tablet 25 mg 20 30 5\n- Eplerenone Tablet 50 mg 20 30 5\n- Eprosartan Tablet 600 mg (as mesilate) 20 28 5\n- Eprosartan with hydrochlorothiazide Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide 20 28 5\n- Erlotinib Tablet 25 mg (as hydrochloride) 20 30 3\n- Erlotinib Tablet 100 mg (as hydrochloride) 20 30 3\n- Erlotinib Tablet 150 mg (as hydrochloride) 20 30 3\n- Escitalopram Tablet 10 mg (as oxalate) 20 28 5\n- Escitalopram Tablet 20 mg (as oxalate) 20 28 5\n- Esomeprazole Capsule (enteric) 20 mg (as magnesium) 20 30 1\n- Esomeprazole Capsule (enteric) 20 mg (as magnesium) 20 30 5\n- Esomeprazole Capsule (enteric) 20 mg (as magnesium) 20 60 5\n- Esomeprazole Capsule (enteric) 40 mg (as magnesium) 20 30 1\n- Esomeprazole Capsule (enteric) 40 mg (as magnesium) 20 30 5\n- Esomeprazole Capsule (enteric) 40 mg (as magnesium) 20 60 5\n- Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) 20 30 1\n- Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) 20 30 5\n- Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) 20 60 5\n- Esomeprazole Tablet (enteric coated) 40 mg (as magnesium) 20 30 1\n- Esomeprazole Tablet (enteric coated) 40 mg (as magnesium) 20 30 5\n- Esomeprazole Tablet (enteric coated) 40 mg (as magnesium) 20 60 5\n- Esomeprazole and clarithromycin and amoxicillin Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) 20 1 0\n- Esomeprazole and clarithromycin and amoxicillin Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) 20 1 0\n- Estetrol with drospirenone Pack containing 24 tablets estetrol 14.2 mg (as monohydrate) with drospirenone 3 mg and 4 inert tablets 20 3 3\n- Estradiol Tablet 2 mg 20 56 2\n- Estradiol Tablet containing estradiol valerate 1 mg 20 56 2\n- Estradiol Tablet containing estradiol valerate 2 mg 20 56 2\n- Estradiol Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses 20 1 5\n- Estradiol Transdermal gel 500 micrograms in 0.5 g sachet, 28 20 1 5\n- Estradiol Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 20 1 5\n- Estradiol Transdermal patches 390 micrograms, 8 20 1 5\n- Estradiol Transdermal patches 390 micrograms, 24 (S19A) 20 1 1\n- Estradiol Transdermal patches 585 micrograms, 8 20 1 5\n- Estradiol Transdermal patches 750 micrograms (as hemihydrate), 8 20 1 5\n- Estradiol Transdermal patches 780 micrograms, 8 20 1 5\n- Estradiol Transdermal patches 780 micrograms, 24 (S19A) 20 1 1\n- Estradiol Transdermal patches 1.17 mg, 8 20 1 5\n- Estradiol Transdermal patches 1.17 mg, 24 (S19A) 20 1 1\n- Estradiol Transdermal patches 1.5 mg (as hemihydrate), 8 20 1 5\n- Estradiol Transdermal patches 1.56 mg, 8 20 1 5\n- Estradiol Transdermal patches 1.56 mg, 24 (Sandoz) (S19A) 20 1 1\n- Estradiol Transdermal patches 3 mg (as hemihydrate), 8 20 1 5\n- Estradiol and estradiol with dydrogesterone Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg 20 1 5\n- Estradiol and estradiol with dydrogesterone Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg 20 1 5\n- Estradiol and estradiol with norethisterone Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate 20 1 5\n- Estradiol and estradiol with norethisterone Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate 20 1 5\n- Estradiol with norethisterone Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 20 1 5\n- Estradiol with norethisterone Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 20 1 5\n- Etanercept Injection 50 mg in 1 mL single use auto-injector, 4 20 1 3\n- Etanercept Injection 50 mg in 1 mL single use auto-injector, 4 20 1 5\n- Etanercept Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL 20 2 3\n- Etanercept Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL 20 2 5\n- Etanercept Injections 50 mg in 1 mL single use pre-filled syringes, 4 20 1 3\n- Etanercept Injections 50 mg in 1 mL single use pre-filled syringes, 4 20 1 5\n- Ethosuximide Capsule 250 mg 20 200 2\n- Etonogestrel Subcutaneous implant 68 mg 20 1 0\n- Etonogestrel with ethinylestradiol Vaginal ring containing etonogestrel 11.7 mg with ethinylestradiol 2.7 mg 20 3 3\n- Etrasimod Tablet 2 mg 20 28 3\n- Etrasimod Tablet 2 mg 20 28 5\n- Evolocumab Injection 140 mg in 1 mL single use pre-filled pen 20 2 5\n- Evolocumab Injection 140 mg in 1 mL single use pre-filled pen 20 3 5\n- Ezetimibe Tablet 10 mg 20 30 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) 20 1 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) 20 1 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) 20 1 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) 20 1 5\n- Ezetimibe with atorvastatin Tablet 10 mg-10 mg 20 30 5\n- Ezetimibe with atorvastatin Tablet 10 mg-20 mg 20 30 5\n- Ezetimibe with atorvastatin Tablet 10 mg-40 mg 20 30 5\n- Ezetimibe with atorvastatin Tablet 10 mg-80 mg 20 30 5\n- Ezetimibe with simvastatin Tablet 10 mg-10 mg 20 30 5\n- Ezetimibe with simvastatin Tablet 10 mg-20 mg 20 30 5\n- Ezetimibe with simvastatin Tablet 10 mg-40 mg 20 30 5\n- Ezetimibe with simvastatin Tablet 10 mg-80 mg 20 30 5\n- Famciclovir Tablet 250 mg 20 56 5\n- Famciclovir Tablet 500 mg 20 56 5\n- Famotidine Tablet 20 mg 20 60 5\n- Famotidine Tablet 40 mg 20 30 5\n- Febuxostat Tablet 80 mg 20 28 5\n- Fedratinib Capsule 100 mg (as hydrochloride) 20 120 5\n- Felodipine Tablet 2.5 mg (extended release) 20 30 5\n- Felodipine Tablet 5 mg (extended release) 20 30 5\n- Felodipine Tablet 10 mg (extended release) 20 30 5\n- Fenofibrate Tablet 48 mg 20 60 5\n- Fenofibrate Tablet 145 mg 20 30 5\n- Fingolimod Capsule 250 micrograms (as hydrochloride) 20 28 5\n- Fingolimod Capsule 500 micrograms (as hydrochloride) 20 28 5\n- Fludarabine Tablet containing fludarabine phosphate 10 mg 20 20 5\n- Fludrocortisone Tablet containing fludrocortisone acetate 100 micrograms 20 200 1\n- Flutamide Tablet 250 mg 20 100 5\n- Fluticasone furoate Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses 20 1 5\n- Fluticasone furoate Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses 20 1 5\n- Fluticasone furoate with umeclidinium and vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 20 1 5\n- Fluticasone furoate with umeclidinium and vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 20 1 5\n- Fluvastatin Tablet (prolonged release) 80 mg (as sodium) 20 28 5\n- Fluvoxamine Tablet containing fluvoxamine maleate 50 mg 20 30 5\n- Fluvoxamine Tablet containing fluvoxamine maleate 100 mg 20 30 5\n- Folic acid Tablet 500 micrograms 20 200 0\n- Folic acid Tablet 5 mg 20 200 1\n- Fosinopril Tablet containing fosinopril sodium 10 mg 20 30 5\n- Fosinopril Tablet containing fosinopril sodium 20 mg 20 30 5\n- Fremanezumab Solution for injection 225 mg in 1.5 mL single dose pre-filled pen 20 1 2\n- Fremanezumab Solution for injection 225 mg in 1.5 mL single dose pre-filled pen 20 1 5\n- Fremanezumab Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe 20 1 2\n- Fremanezumab Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe 20 1 5\n- Furosemide Tablet 20 mg 20 100 1\n- Furosemide Tablet 40 mg 20 100 1\n- Gabapentin Capsule 100 mg 20 100 5\n- Gabapentin Capsule 300 mg 20 100 5\n- Gabapentin Capsule 400 mg 20 100 5\n- Gabapentin Tablet 600 mg 20 100 5\n- Gabapentin Tablet 800 mg 20 100 5\n- Galantamine Capsule (prolonged release) 8 mg (as hydrobromide) 20 28 5\n- Galantamine Capsule (prolonged release) 16 mg (as hydrobromide) 20 28 5\n- Galantamine Capsule (prolonged release) 24 mg (as hydrobromide) 20 28 5\n- Galcanezumab Injection 120 mg in 1 mL pre-filled pen 20 1 5\n- Galcanezumab Injection 120 mg in 1 mL pre-filled pen 20 2 1\n- Garadacimab Injection 200 mg in 1.2 mL pre-filled pen 20 1 4\n- Garadacimab Injection 200 mg in 1.2 mL pre-filled pen 20 1 5\n- Garadacimab Injection 200 mg in 1.2 mL pre-filled pen 20 2 0\n- Gemfibrozil Tablet 600 mg 20 60 5\n- Givosiran Solution for injection 189 mg in 1 mL 20 2 5\n- Gliclazide Tablet 60 mg (modified release) 20 60 5\n- Gliclazide Tablet 80 mg 20 100 5\n- Glimepiride Tablet 3 mg 20 30 5\n- Glimepiride Tablet 4 mg 20 30 5\n- Glyceryl trinitrate Transdermal patch 18 mg 20 30 5\n- Glyceryl trinitrate Transdermal patch 25 mg 20 30 5\n- Glyceryl trinitrate Transdermal patch 50 mg 20 30 5\n- Glycopyrronium Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) 20 30 5\n- Golimumab Injection 50 mg in 0.5 mL single use pre-filled pen 20 1 5\n- Golimumab Injection 50 mg in 0.5 mL single use pre-filled syringe 20 1 5\n- Golimumab Injection 100 mg in 1 mL single use pre-filled pen 20 1 5\n- Goserelin Subcutaneous implant 3.6 mg (as acetate) in pre-filled injection syringe 20 1 5\n- Goserelin Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre-filled injection syringe 20 1 1\n- Goserelin and bicalutamide Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg 20 1 5\n- Goserelin and bicalutamide Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg 20 1 0\n- Goserelin and bicalutamide Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 84 tablets bicalutamide 50 mg 20 1 1\n- Griseofulvin Tablet 125 mg 20 100 2\n- Guanfacine Tablet 1 mg (as hydrochloride) 20 28 5\n- Guanfacine Tablet 2 mg (as hydrochloride) 20 28 5\n- Guanfacine Tablet 3 mg (as hydrochloride) 20 28 5\n- Guanfacine Tablet 4 mg (as hydrochloride) 20 28 5\n- Hydrochlorothiazide Tablet 25 mg 20 100 1\n- Hydrochlorothiazide with amiloride Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg 20 100 1\n- Hydroxocobalamin Injection 1 mg (as acetate) in 1 mL 20 3 0\n- Hydroxocobalamin Injection 1 mg (as chloride) in 1 mL 20 3 0\n- Hydroxychloroquine Tablet containing hydroxychloroquine sulfate 200 mg 20 100 1\n- Ibandronic acid Tablet 50 mg (as ibandronate sodium monohydrate) 20 28 2\n- Ibrutinib Capsule 140 mg 20 90 2\n- Ibrutinib Capsule 140 mg 20 90 4\n- Ibrutinib Capsule 140 mg 20 90 5\n- Ibrutinib Capsule 140 mg 20 120 5\n- Ibrutinib Tablet 280 mg 20 30 2\n- Ibrutinib Tablet 280 mg 20 30 4\n- Ibrutinib Tablet 280 mg 20 30 5\n- Ibrutinib Tablet 420 mg 20 30 2\n- Ibrutinib Tablet 420 mg 20 30 4\n- Ibrutinib Tablet 420 mg 20 30 5\n- Ibrutinib Tablet 560 mg 20 30 5\n- Icosapent ethyl Capsule 998 mg 20 120 5\n- Idelalisib Tablet 100 mg 20 60 5\n- Idelalisib Tablet 150 mg 20 60 5\n- Imatinib Capsule 100 mg (as mesilate) 20 60 2\n- Imatinib Capsule 100 mg (as mesilate) 20 60 5\n- Imatinib Capsule 400 mg (as mesilate) 20 30 2\n- Imatinib Capsule 400 mg (as mesilate) 20 30 5\n- Imatinib Tablet 100 mg (as mesilate) 20 60 2\n- Imatinib Tablet 100 mg (as mesilate) 20 60 5\n- Imatinib Tablet 400 mg (as mesilate) 20 30 2\n- Imatinib Tablet 400 mg (as mesilate) 20 30 5\n- Imatinib Tablet 600 mg (as mesilate) 20 30 2\n- Imatinib Tablet 600 mg (as mesilate) 20 30 5\n- Indacaterol Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) 20 30 5\n- Indacaterol Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) 20 30 5\n- Indacaterol with glycopyrronium Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) 20 30 5\n- Indacaterol with glycopyrronium and mometasone Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler) 20 30 5\n- Indacaterol with glycopyrronium and mometasone Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler) 20 30 5\n- Indapamide Tablet containing indapamide hemihydrate 1.5 mg (sustained release) 20 90 1\n- Indapamide Tablet containing indapamide hemihydrate 2.5 mg 20 90 1\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled pen 20 1 0\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled pen 20 2 0\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled pen 20 2 2\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled pen 20 2 5\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled syringe 20 1 0\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled syringe 20 2 0\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled syringe 20 2 2\n- Infliximab Solution for injection 120 mg in 1 mL pre-filled syringe 20 2 5\n- Insulin aspart Injection (human analogue) 100 units per mL, 10 mL vial 20 5 2\n- Insulin aspart Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin aspart Injections (human analogue) (fast acting), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin aspart with insulin aspart protamine suspension Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 20 5 1\n- Insulin detemir Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin glulisine Injection (human analogue) 100 units per mL, 10 mL 20 5 2\n- Insulin glulisine Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin isophane Injection (human) 100 units per mL, 10 mL 20 5 2\n- Insulin isophane Injections (human), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin lispro Injection (human analogue) 100 units per mL, 10 mL vial 20 5 2\n- Insulin lispro Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin lispro Injections (human analogue), pre-filled pen, 200 units per mL, 3 mL, 5 20 5 1\n- Insulin lispro with insulin lispro protamine suspension Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 20 5 1\n- Insulin lispro with insulin lispro protamine suspension Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 20 5 1\n- Insulin neutral Injection (human) 100 units per mL, 10 mL 20 5 2\n- Insulin neutral Injections (human), cartridges, 100 units per mL, 3 mL, 5 20 5 1\n- Insulin neutral with insulin isophane Injection (human) 30 units-70 units per mL, 10 mL 20 5 2\n- Insulin neutral with insulin isophane Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 20 5 1\n- Irbesartan Tablet 75 mg 20 30 5\n- Irbesartan Tablet 150 mg 20 30 5\n- Irbesartan Tablet 300 mg 20 30 5\n- Irbesartan with hydrochlorothiazide Tablet 150 mg-12.5 mg 20 30 5\n- Irbesartan with hydrochlorothiazide Tablet 300 mg-12.5 mg 20 30 5\n- Irbesartan with hydrochlorothiazide Tablet 300 mg-25 mg 20 30 5\n- Isosorbide mononitrate Tablet 60 mg (sustained release) 20 30 5\n- Isosorbide mononitrate Tablet 120 mg (sustained release) 20 30 5\n- Ivabradine Tablet 5 mg (as hydrochloride) 20 56 5\n- Ivabradine Tablet 7.5 mg (as hydrochloride) 20 56 5\n- Ivosidenib Tablet 250 mg 20 60 5\n- Ixekizumab Injection 80 mg in 1 mL single dose pre-filled pen 20 2 2\n- Labetalol Tablet containing labetalol hydrochloride 100 mg 20 100 5\n- Lacosamide Tablet 100 mg 20 56 5\n- Lacosamide Tablet 150 mg 20 56 5\n- Lacosamide Tablet 200 mg 20 56 5\n- Lamotrigine Tablet 5 mg 20 56 5\n- Lamotrigine Tablet 25 mg 20 56 5\n- Lamotrigine Tablet 50 mg 20 56 5\n- Lamotrigine Tablet 100 mg 20 56 5\n- Lamotrigine Tablet 200 mg 20 56 5\n- Lanadelumab Injection 300 mg in 2 mL single use pre-filled syringe 20 1 5\n- Lansoprazole Capsule 15 mg 20 30 5\n- Lansoprazole Capsule 30 mg 20 28 1\n- Lansoprazole Capsule 30 mg 20 28 5\n- Lansoprazole Capsule 30 mg 20 56 5\n- Lansoprazole Tablet 15 mg (orally disintegrating) 20 28 5\n- Lansoprazole Tablet 30 mg (orally disintegrating) 20 28 1\n- Lansoprazole Tablet 30 mg (orally disintegrating) 20 28 5\n- Lansoprazole Tablet 30 mg (orally disintegrating) 20 56 5\n- Leflunomide Tablet 10 mg 20 30 5\n- Leflunomide Tablet 20 mg 20 30 5\n- Lercanidipine Tablet containing lercanidipine hydrochloride 10 mg 20 28 5\n- Lercanidipine Tablet containing lercanidipine hydrochloride 20 mg 20 28 5\n- Lercanidipine with enalapril Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg 20 28 5\n- Lercanidipine with enalapril Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg 20 28 5\n- Letrozole Tablet 2.5 mg 20 30 5\n- Leuprorelin I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe 20 1 1\n- Leuprorelin I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre-filled dual-chamber syringe 20 1 5\n- Leuprorelin I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre-filled dual-chamber syringe 20 1 1\n- Leuprorelin I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre-filled dual-chamber syringe 20 1 1\n- Leuprorelin I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre-filled dual-chamber syringe 20 1 0\n- Leuprorelin Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set 20 1 5\n- Leuprorelin Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set 20 1 1\n- Leuprorelin Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set 20 1 1\n- Leuprorelin Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set 20 1 0\n- Leuprorelin and bicalutamide Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg 20 1 5\n- Leuprorelin and bicalutamide Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg 20 1 0\n- Leuprorelin and bicalutamide Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg 20 1 1\n- Levetiracetam Oral solution 100 mg per mL, 300 mL 20 1 5\n- Levetiracetam Tablet 250 mg 20 60 5\n- Levetiracetam Tablet 500 mg 20 60 5\n- Levetiracetam Tablet 1 g 20 60 5\n- Levodopa with carbidopa and entacapone Tablet 50 mg-12.5 mg (as monohydrate)-200 mg 20 200 4\n- Levodopa with carbidopa and entacapone Tablet 75 mg-18.75 mg (as monohydrate)-200 mg 20 200 4\n- Levodopa with carbidopa and entacapone Tablet 100 mg-25 mg (as monohydrate)-200 mg 20 200 4\n- Levodopa with carbidopa and entacapone Tablet 125 mg-31.25 mg (as monohydrate)-200 mg 20 200 4\n- Levodopa with carbidopa and entacapone Tablet 150 mg-37.5 mg (as monohydrate)-200 mg 20 200 4\n- Levodopa with carbidopa and entacapone Tablet 200 mg-50 mg (as monohydrate)-200 mg 20 200 4\n- Levonorgestrel Intrauterine drug delivery system 19.5 mg 20 1 0\n- Levonorgestrel Intrauterine drug delivery system 52 mg 20 1 0\n- Levonorgestrel Tablets 30 micrograms, 28 20 4 2\n- Levonorgestrel with ethinylestradiol Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets 20 4 2\n- Levonorgestrel with ethinylestradiol Pack containing 21 tablets 100 micrograms-20 micrograms and 7 inert tablets 20 4 2\n- Levonorgestrel with ethinylestradiol Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets 20 4 2\n- Levonorgestrel with ethinylestradiol Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets 20 4 2\n- Levothyroxine Tablet containing 50 micrograms anhydrous levothyroxine sodium 20 200 1\n- Levothyroxine Tablet containing 75 micrograms anhydrous levothyroxine sodium 20 200 1\n- Levothyroxine Tablet containing 100 micrograms anhydrous levothyroxine sodium 20 200 1\n- Levothyroxine Tablet containing 125 micrograms anhydrous levothyroxine sodium 20 200 1\n- Levothyroxine Tablet containing 200 micrograms anhydrous levothyroxine sodium 20 200 1\n- Linagliptin Tablet 5 mg 20 30 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride 20 60 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride 20 60 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride 20 60 5\n- Liothyronine Tablet containing liothyronine sodium 20 micrograms 20 100 2\n- Lisinopril Tablet 5 mg 20 30 5\n- Lisinopril Tablet 10 mg 20 30 5\n- Lisinopril Tablet 20 mg 20 30 5\n- Lumasiran Solution for subcutaneous injection 94.5 mg (as sodium) in 0.5 mL 20 5 1\n- Lumasiran Solution for subcutaneous injection 94.5 mg (as sodium) in 0.5 mL 20 5 2\n- Medroxyprogesterone Injection containing medroxyprogesterone acetate 150 mg in 1 mL pre-filled syringe 20 1 1\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 5 mg 20 56 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 10 mg 20 30 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 10 mg 20 100 2\n- Melatonin Tablet 1 mg (modified release) 20 60 5\n- Melatonin Tablet 5 mg (modified release) 20 30 5\n- Meloxicam Capsule 15 mg 20 30 3\n- Meloxicam Tablet 15 mg 20 30 3\n- Memantine Tablet containing memantine hydrochloride 10 mg 20 56 5\n- Memantine Tablet containing memantine hydrochloride 20 mg 20 28 5\n- Mesalazine Sachet containing granules, 500 mg per sachet 20 200 5\n- Mesalazine Sachet containing granules, 1 g per sachet 20 100 5\n- Mesalazine Sachet containing granules, 1.5 g per sachet 20 60 5\n- Mesalazine Sachet containing granules, 3 g per sachet 20 30 5\n- Mesalazine Sachet containing prolonged release granules, 1 g per sachet 20 100 5\n- Mesalazine Sachet containing prolonged release granules, 2 g per sachet 20 60 5\n- Mesalazine Sachet containing prolonged release granules, 4 g per sachet 20 30 5\n- Mesalazine Tablet 250 mg (enteric coated) 20 100 5\n- Mesalazine Tablet 500 mg (enteric coated) 20 200 5\n- Mesalazine Tablet 500 mg (prolonged release) 20 200 5\n- Mesalazine Tablet 800 mg (enteric coated) 20 90 5\n- Mesalazine Tablet 1 g (enteric coated) 20 120 5\n- Mesalazine Tablet 1 g (prolonged release) 20 120 5\n- Mesalazine Tablet 1.2 g (prolonged release) 20 120 5\n- Mesalazine Tablet 1.6 g (enteric coated) 20 120 4\n- Metformin Tablet containing metformin hydrochloride 500 mg 20 100 5\n- Metformin Tablet containing metformin hydrochloride 850 mg 20 60 5\n- Metformin Tablet containing metformin hydrochloride 1 g 20 90 5\n- Metformin Tablet (extended release) containing metformin hydrochloride 500 mg 20 120 5\n- Metformin Tablet (extended release) containing metformin hydrochloride 1 g 20 60 5\n- Methadone Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL 20 840 5\n- Methadone Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL 20 840 5\n- Methotrexate Injection 7.5 mg in 0.15 mL pre-filled syringe 20 4 5\n- Methotrexate Injection 10 mg in 0.2 mL pre-filled syringe 20 4 5\n- Methotrexate Injection 15 mg in 0.3 mL pre-filled syringe 20 4 5\n- Methotrexate Injection 20 mg in 0.4 mL pre-filled syringe 20 4 5\n- Methotrexate Injection 25 mg in 0.5 mL pre-filled syringe 20 4 5\n- Methotrexate Tablet 10 mg 20 10 5\n- Methyldopa Tablet 250 mg (as sesquihydrate) 20 100 5\n- Methylprednisolone Injection containing methylprednisolone acetate 40 mg in 1 mL 20 5 0\n- Metoprolol Tablet containing metoprolol tartrate 50 mg 20 100 5\n- Metoprolol Tablet containing metoprolol tartrate 100 mg 20 60 5\n- Metoprolol succinate Tablet 47.5 mg (controlled release) 20 30 5\n- Metoprolol succinate Tablet 95 mg (controlled release) 20 30 5\n- Metoprolol succinate Tablet 190 mg (controlled release) 20 30 5\n- Migalastat Capsule containing 150 mg migalastat hydrochloride (equivalent to 123 mg migalastat) 20 14 6\n- Minocycline Tablet 50 mg (as hydrochloride) 20 60 5\n- Minoxidil Tablet 10 mg 20 100 5\n- Mirtazapine Tablet 45 mg 20 30 5\n- Mirtazapine Tablet 45 mg (orally disintegrating) 20 30 5\n- Moclobemide Tablet 150 mg 20 60 5\n- Moclobemide Tablet 300 mg 20 60 5\n- Modafinil Tablet 100 mg 20 120 5\n- Momelotinib Tablet 100 mg (as dihydrochloride monohydrate) 20 30 0\n- Momelotinib Tablet 100 mg (as dihydrochloride monohydrate) 20 30 5\n- Momelotinib Tablet 150 mg (as dihydrochloride monohydrate) 20 30 0\n- Momelotinib Tablet 150 mg (as dihydrochloride monohydrate) 20 30 5\n- Momelotinib Tablet 200 mg (as dihydrochloride monohydrate) 20 30 0\n- Momelotinib Tablet 200 mg (as dihydrochloride monohydrate) 20 30 5\n- Montelukast Tablet, chewable, 4 mg (as sodium) 20 28 5\n- Montelukast Tablet, chewable, 5 mg (as sodium) 20 28 5\n- Moxonidine Tablet 200 micrograms 20 30 5\n- Moxonidine Tablet 400 micrograms 20 30 5\n- Nafarelin Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses 20 1 5\n- Naproxen Tablet 750 mg (sustained release) 20 28 0\n- Naproxen Tablet 750 mg (sustained release) 20 28 3\n- Naproxen Tablet 1 g (sustained release) 20 28 0\n- Naproxen Tablet 1 g (sustained release) 20 28 3\n- Nebivolol Tablet 1.25 mg (as hydrochloride) 20 56 5\n- Nebivolol Tablet 5 mg (as hydrochloride) 20 28 5\n- Nebivolol Tablet 10 mg (as hydrochloride) 20 28 5\n- Nicorandil Tablets 10 mg, 60 20 1 5\n- Nicorandil Tablets 20 mg, 60 20 1 5\n- Nifedipine Tablet 30 mg (controlled release) 20 30 5\n- Nifedipine Tablet 60 mg (controlled release) 20 30 5\n- Nilotinib Capsule 150 mg (as hydrochloride monohydrate) 20 120 5\n- Nilotinib Capsule 200 mg (as hydrochloride monohydrate) 20 120 5\n- Nintedanib Capsule 100 mg 20 60 5\n- Nintedanib Capsule 150 mg 20 60 5\n- Niraparib Tablet 100 mg (as tosilate monohydrate) 20 56 2\n- Niraparib Tablet 100 mg (as tosilate monohydrate) 20 56 5\n- Niraparib Tablet 100 mg (as tosilate monohydrate) 20 84 2\n- Niraparib Tablet 100 mg (as tosilate monohydrate) 20 84 5\n- Nizatidine Capsule 150 mg 20 60 5\n- Nizatidine Capsule 300 mg 20 30 5\n- Norethisterone Tablets 350 micrograms, 28 20 4 2\n- Norethisterone with ethinylestradiol Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets 20 4 2\n- Norethisterone with ethinylestradiol Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets 20 4 2\n- Obeticholic acid Tablet 5 mg 20 30 5\n- Obeticholic acid Tablet 10 mg 20 30 5\n- Odevixibat Capsule 200 micrograms 20 360 2\n- Odevixibat Capsule 200 micrograms 20 360 4\n- Odevixibat Capsule 200 micrograms 20 360 5\n- Odevixibat Capsule 400 micrograms 20 180 2\n- Odevixibat Capsule 400 micrograms 20 180 4\n- Odevixibat Capsule 400 micrograms 20 180 5\n- Odevixibat Capsule 600 micrograms 20 360 2\n- Odevixibat Capsule 600 micrograms 20 360 4\n- Odevixibat Capsule 600 micrograms 20 360 5\n- Odevixibat Capsule 1.2 mg 20 180 2\n- Odevixibat Capsule 1.2 mg 20 180 4\n- Odevixibat Capsule 1.2 mg 20 180 5\n- Ofatumumab Solution for injection 20 mg in 0.4 mL pre-filled pen 20 1 5\n- Ofatumumab Solution for injection 20 mg in 0.4 mL pre-filled pen 20 3 0\n- Olaparib Tablet 100 mg 20 112 5\n- Olaparib Tablet 100 mg 20 112 6\n- Olaparib Tablet 150 mg 20 112 5\n- Olaparib Tablet 150 mg 20 112 6\n- Olmesartan Tablet containing olmesartan medoxomil 20 mg 20 30 5\n- Olmesartan Tablet containing olmesartan medoxomil 40 mg 20 30 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) 20 30 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) 20 30 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) 20 30 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg 20 30 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg 20 30 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg 20 30 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg 20 30 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg 20 30 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg 20 30 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg 20 30 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg 20 30 5\n- Olsalazine Capsule containing olsalazine sodium 250 mg 20 100 5\n- Olsalazine Tablet containing olsalazine sodium 500 mg 20 100 5\n- Omeprazole Capsule 20 mg 20 30 1\n- Omeprazole Capsule 20 mg 20 30 5\n- Omeprazole Capsule 20 mg 20 60 5\n- Omeprazole Tablet 10 mg (as magnesium) 20 30 5\n- Omeprazole Tablet 20 mg 20 30 1\n- Omeprazole Tablet 20 mg 20 30 5\n- Omeprazole Tablet 20 mg 20 60 5\n- Omeprazole Tablet 20 mg (as magnesium) 20 30 1\n- Omeprazole Tablet 20 mg (as magnesium) 20 30 5\n- Omeprazole Tablet 20 mg (as magnesium) 20 60 5\n- Opicapone Capsule 50 mg 20 30 5\n- Oxcarbazepine Tablet 600 mg 20 100 5\n- Oxybutynin Tablet containing oxybutynin hydrochloride 5 mg 20 100 5\n- Oxybutynin Transdermal patches 36 mg, 8 20 1 5\n- Ozanimod Capsule 920 micrograms 20 28 3\n- Ozanimod Capsule 920 micrograms 20 28 5\n- Ozanimod Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms 20 1 0\n- Palbociclib Tablet 75 mg 20 21 5\n- Palbociclib Tablet 100 mg 20 21 5\n- Palbociclib Tablet 125 mg 20 21 5\n- Pantoprazole Sachet containing granules 40 mg (as sodium sesquihydrate) 20 30 1\n- Pantoprazole Sachet containing granules 40 mg (as sodium sesquihydrate) 20 30 5\n- Pantoprazole Sachet containing granules 40 mg (as sodium sesquihydrate) 20 60 5\n- Pantoprazole Tablet (enteric coated) 20 mg (as sodium sesquihydrate) 20 30 5\n- Pantoprazole Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 20 30 1\n- Pantoprazole Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 20 30 5\n- Pantoprazole Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 20 60 5\n- Paracetamol Tablet 500 mg 20 300 0\n- Paracetamol Tablet 665 mg (modified release) 20 192 5\n- Paroxetine Tablet 20 mg (as hydrochloride) 20 30 5\n- Patiromer Powder for oral suspension 8.4 g 20 30 5\n- Patiromer Powder for oral suspension 16.8 g 20 30 5\n- Pazopanib Tablet 200 mg (as hydrochloride) 20 30 5\n- Pazopanib Tablet 200 mg (as hydrochloride) 20 90 2\n- Pazopanib Tablet 200 mg (as hydrochloride) 20 90 5\n- Pazopanib Tablet 400 mg (as hydrochloride) 20 30 5\n- Pazopanib Tablet 400 mg (as hydrochloride) 20 60 2\n- Pazopanib Tablet 400 mg (as hydrochloride) 20 60 5\n- Perampanel Tablet 4 mg (as hemisesquihydrate) 20 28 5\n- Perampanel Tablet 6 mg (as hemisesquihydrate) 20 28 5\n- Perampanel Tablet 8 mg (as hemisesquihydrate) 20 28 5\n- Perampanel Tablet 10 mg (as hemisesquihydrate) 20 28 5\n- Perampanel Tablet 12 mg (as hemisesquihydrate) 20 28 5\n- Perhexiline Tablet containing perhexiline maleate 100 mg 20 100 5\n- Perindopril Tablet containing perindopril arginine 2.5 mg 20 30 5\n- Perindopril Tablet containing perindopril arginine 5 mg 20 30 5\n- Perindopril Tablet containing perindopril arginine 10 mg 20 30 5\n- Perindopril Tablet containing perindopril erbumine 2 mg 20 30 5\n- Perindopril Tablet containing perindopril erbumine 4 mg 20 30 5\n- Perindopril Tablet containing perindopril erbumine 8 mg 20 30 5\n- Perindopril with amlodipine Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) 20 30 5\n- Perindopril with amlodipine Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) 20 30 5\n- Perindopril with amlodipine Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) 20 30 5\n- Perindopril with amlodipine Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) 20 30 5\n- Perindopril with indapamide Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg 20 30 5\n- Perindopril with indapamide Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg 20 30 5\n- Perindopril with indapamide Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg 20 30 5\n- Phenobarbital Tablet 30 mg 20 200 4\n- Phenoxybenzamine Capsule containing phenoxybenzamine hydrochloride 10 mg 20 100 5\n- Phenytoin Capsule containing phenytoin sodium 30 mg 20 200 2\n- Phenytoin Capsule containing phenytoin sodium 100 mg 20 200 2\n- Phenytoin Tablet 50 mg 20 200 2\n- Pioglitazone Tablet 15 mg (as hydrochloride), pack of 30 20 1 5\n- Pioglitazone Tablet 30 mg (as hydrochloride), pack of 30 20 1 5\n- Pioglitazone Tablet 45 mg (as hydrochloride) 20 28 5\n- Pioglitazone Tablet 45 mg (as hydrochloride), pack of 30 20 1 5\n- Pirfenidone Tablet 267 mg 20 270 5\n- Pirfenidone Tablet 801 mg 20 90 5\n- Pizotifen Tablet 500 micrograms (as malate) 20 100 2\n- Ponatinib Tablet 15 mg (as hydrochloride) 20 60 2\n- Ponatinib Tablet 15 mg (as hydrochloride) 20 60 5\n- Ponatinib Tablet 45 mg (as hydrochloride) 20 30 2\n- Ponatinib Tablet 45 mg (as hydrochloride) 20 30 5\n- Potassium chloride Tablet 600 mg (sustained release) 20 200 1\n- Potassium chloride with potassium bicarbonate Tablet, effervescent, 14 mmol potassium and 8 mmol chloride 20 60 1\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg 20 30 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg 20 30 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg 20 30 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg 20 30 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg 20 30 5\n- Prasugrel Tablet 5 mg 20 28 5\n- Prasugrel Tablet 10 mg 20 28 5\n- Pravastatin Tablet containing pravastatin sodium 10 mg 20 30 5\n- Pravastatin Tablet containing pravastatin sodium 20 mg 20 30 5\n- Pravastatin Tablet containing pravastatin sodium 40 mg 20 30 5\n- Pravastatin Tablet containing pravastatin sodium 80 mg 20 30 5\n- Prazosin Capsule 1 mg (as hydrochloride) (S19A) 20 100 5\n- Prazosin Capsule 2 mg (as hydrochloride) (S19A) 20 100 5\n- Prazosin Tablet 1 mg (as hydrochloride) 20 100 5\n- Prazosin Tablet 2 mg (as hydrochloride) 20 100 5\n- Prazosin Tablet 5 mg (as hydrochloride) 20 100 5\n- Pregabalin Capsule 300 mg 20 56 5\n- Primidone Tablet 250 mg 20 200 2\n- Probenecid Tablet 500 mg 20 100 5\n- Progesterone Capsule 100 mg 20 30 5\n- Progesterone and estradiol Pack containing 30 capsules progesterone 100 mg (micronised) and transdermal gel (pump pack) estradiol 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses 20 1 5\n- Propantheline Tablet containing propantheline bromide 15 mg 20 200 5\n- Propranolol Tablet containing propranolol hydrochloride 10 mg 20 100 5\n- Propranolol Tablet containing propranolol hydrochloride 40 mg 20 100 5\n- Quinapril Tablet 5 mg (as hydrochloride) 20 30 5\n- Quinapril Tablet 10 mg (as hydrochloride) 20 30 5\n- Quinapril Tablet 20 mg (as hydrochloride) 20 30 5\n- Rabeprazole Tablet containing rabeprazole sodium 10 mg (enteric coated) 20 28 5\n- Rabeprazole Tablet containing rabeprazole sodium 20 mg (enteric coated) 20 30 1\n- Rabeprazole Tablet containing rabeprazole sodium 20 mg (enteric coated) 20 30 5\n- Rabeprazole Tablet containing rabeprazole sodium 20 mg (enteric coated) 20 60 5\n- Raloxifene Tablet containing raloxifene hydrochloride 60 mg 20 28 5\n- Raltegravir Tablet 600 mg (as potassium) 20 120 5\n- Ramipril Capsule 1.25 mg 20 30 5\n- Ramipril Capsule 2.5 mg 20 30 5\n- Ramipril Capsule 5 mg 20 30 5\n- Ramipril Capsule 10 mg 20 30 5\n- Ramipril Tablet 1.25 mg 20 30 5\n- Ramipril Tablet 2.5 mg 20 30 5\n- Ramipril Tablet 5 mg 20 30 5\n- Ramipril Tablet 10 mg 20 30 5\n- Ramipril with felodipine Tablet 5 mg-5 mg (modified release) 20 30 5\n- Ranitidine Tablet 150 mg (as hydrochloride) 20 60 5\n- Ranitidine Tablet 300 mg (as hydrochloride) 20 30 5\n- Rasagiline Tablet 1 mg (as mesilate) 20 30 5\n- Reboxetine Tablet 4 mg (as mesilate) 20 60 5\n- Relugolix with estradiol and with norethisterone Tablet containing relugolix 40 mg with estradiol (as hemihydrate) 1 mg and with norethisterone acetate 500 micrograms 20 28 5\n- Ribociclib Tablet 200 mg 20 21 5\n- Ribociclib Tablet 200 mg 20 42 5\n- Ribociclib Tablet 200 mg 20 63 5\n- Rifaximin Tablet 550 mg 20 56 5\n- Riluzole Tablet 50 mg 20 56 5\n- Ripretinib Tablet 50 mg 20 90 1\n- Risankizumab Injection 150 mg in 1 mL pre-filled pen 20 1 1\n- Risankizumab Injection 150 mg in 1 mL pre-filled pen 20 1 2\n- Risedronic acid Tablet containing risedronate sodium 5 mg 20 28 5\n- Risedronic acid Tablet containing risedronate sodium 30 mg 20 28 1\n- Risedronic acid Tablet containing risedronate sodium 35 mg 20 4 5\n- Risedronic acid Tablet containing risedronate sodium 150 mg 20 1 5\n- Risedronic acid Tablet (enteric coated) containing risedronate sodium 35 mg 20 4 5\n- Rivaroxaban Capsule 15 mg 20 28 5\n- Rivaroxaban Capsule 20 mg 20 28 5\n- Rivaroxaban Tablet 2.5 mg 20 60 5\n- Rivaroxaban Tablet 10 mg 20 30 5\n- Rivaroxaban Tablet 15 mg 20 28 5\n- Rivaroxaban Tablet 20 mg 20 28 5\n- Rivastigmine Capsule 1.5 mg (as hydrogen tartrate) 20 56 5\n- Rivastigmine Capsule 3 mg (as hydrogen tartrate) 20 56 5\n- Rivastigmine Capsule 4.5 mg (as hydrogen tartrate) 20 56 5\n- Rivastigmine Capsule 6 mg (as hydrogen tartrate) 20 56 5\n- Rivastigmine Transdermal patch 9 mg 20 30 5\n- Rivastigmine Transdermal patch 18 mg 20 30 5\n- Rivastigmine Transdermal patch 27 mg 20 30 5\n- Romosozumab Injection 105 mg in 1.17 mL single use pre-filled syringe 20 2 5\n- Rosuvastatin Tablet 5 mg (as calcium) 20 30 5\n- Rosuvastatin Tablet 10 mg (as calcium) 20 30 5\n- Rosuvastatin Tablet 20 mg (as calcium) 20 30 5\n- Rosuvastatin Tablet 40 mg (as calcium) 20 30 5\n- Rotigotine Transdermal patch 4.5 mg 20 28 5\n- Rotigotine Transdermal patch 9 mg 20 28 5\n- Rotigotine Transdermal patch 13.5 mg 20 28 5\n- Rotigotine Transdermal patch 18 mg 20 28 5\n- Ruxolitinib Tablet 5 mg 20 56 5\n- Ruxolitinib Tablet 5 mg 20 112 0\n- Ruxolitinib Tablet 5 mg 20 112 5\n- Ruxolitinib Tablet 10 mg 20 56 0\n- Ruxolitinib Tablet 10 mg 20 56 5\n- Ruxolitinib Tablet 15 mg 20 56 0\n- Ruxolitinib Tablet 15 mg 20 56 5\n- Ruxolitinib Tablet 20 mg 20 56 0\n- Ruxolitinib Tablet 20 mg 20 56 5\n- Sacubitril with valsartan Tablet containing sacubitril 24.3 mg with valsartan 25.7 mg 20 56 5\n- Sacubitril with valsartan Tablet containing sacubitril 48.6 mg with valsartan 51.4 mg 20 56 5\n- Sacubitril with valsartan Tablet containing sacubitril 97.2 mg with valsartan 102.8 mg 20 56 5\n- Safinamide Tablet 50 mg 20 30 5\n- Safinamide Tablet 100 mg 20 30 5\n- Sapropterin Powder for oral solution 500 mg (as dihydrochloride) 20 30 5\n- Sapropterin Tablet (soluble) containing sapropterin dihydrochloride 100 mg 20 180 5\n- Saxagliptin Tablet 2.5 mg (as hydrochloride) 20 28 5\n- Saxagliptin Tablet 5 mg (as hydrochloride) 20 28 5\n- Saxagliptin with dapagliflozin Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg 20 28 5\n- Saxagliptin with metformin Tablet (modified release) containing 2.5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride 20 56 5\n- Saxagliptin with metformin Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 500 mg metformin hydrochloride 20 28 5\n- Saxagliptin with metformin Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride 20 28 5\n- Secukinumab Injection 150 mg in 1 mL pre-filled pen 20 1 5\n- Secukinumab Injection 150 mg in 1 mL pre-filled pen 20 2 3\n- Secukinumab Injection 150 mg in 1 mL pre-filled pen 20 2 5\n- Secukinumab Injection 150 mg in 1 mL pre-filled pen 20 8 0\n- Secukinumab Injection 300 mg in 2 mL pre-filled pen 20 1 3\n- Secukinumab Injection 300 mg in 2 mL pre-filled pen 20 1 5\n- Secukinumab Injection 300 mg in 2 mL pre-filled pen 20 4 0\n- Selegiline Tablet containing selegiline hydrochloride 5 mg 20 100 5\n- Selpercatinib Capsule 40 mg 20 56 5\n- Selpercatinib Capsule 80 mg 20 112 5\n- Selumetinib Capsule 10 mg 20 60 5\n- Selumetinib Capsule 25 mg 20 60 5\n- Sertraline Tablet 50 mg (as hydrochloride) 20 30 5\n- Sertraline Tablet 100 mg (as hydrochloride) 20 30 5\n- Sevelamer Tablet containing sevelamer carbonate 800 mg 20 180 5\n- Sevelamer Tablet containing sevelamer hydrochloride 800 mg 20 180 5\n- Simvastatin Tablet 5 mg 20 30 5\n- Simvastatin Tablet 10 mg 20 30 5\n- Simvastatin Tablet 20 mg 20 30 5\n- Simvastatin Tablet 40 mg 20 30 5\n- Simvastatin Tablet 80 mg 20 30 5\n- Siponimod Tablet 1 mg (as hemifumarate) 20 28 5\n- Siponimod Tablet 2 mg (as hemifumarate) 20 28 5\n- Sitagliptin Tablet 25 mg 20 28 5\n- Sitagliptin Tablet 50 mg 20 28 5\n- Sitagliptin Tablet 100 mg 20 28 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride 20 56 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride 20 56 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride 20 56 5\n- Sitagliptin with metformin Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride 20 56 5\n- Sitagliptin with metformin Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride 20 28 5\n- Sonidegib Capsule 200 mg 20 30 3\n- Sorafenib Tablet 200 mg (as tosilate) 20 120 2\n- Sorafenib Tablet 200 mg (as tosilate) 20 120 5\n- Spironolactone Tablet 25 mg 20 100 5\n- Spironolactone Tablet 100 mg 20 100 5\n- Sulfasalazine Tablet 500 mg 20 200 5\n- Sulfasalazine Tablet 500 mg (enteric coated) 20 200 5\n- Sulthiame Tablet 50 mg 20 200 2\n- Sulthiame Tablet 200 mg 20 200 2\n- Sunitinib Capsule 12.5 mg 20 28 1\n- Sunitinib Capsule 12.5 mg 20 28 2\n- Sunitinib Capsule 12.5 mg 20 28 3\n- Sunitinib Capsule 12.5 mg 20 28 5\n- Sunitinib Capsule 25 mg 20 28 1\n- Sunitinib Capsule 25 mg 20 28 2\n- Sunitinib Capsule 25 mg 20 28 3\n- Sunitinib Capsule 25 mg 20 28 5\n- Sunitinib Capsule 37.5 mg 20 28 1\n- Sunitinib Capsule 37.5 mg 20 28 2\n- Sunitinib Capsule 37.5 mg 20 28 3\n- Sunitinib Capsule 37.5 mg 20 28 5\n- Sunitinib Capsule 50 mg 20 28 1\n- Sunitinib Capsule 50 mg 20 28 2\n- Sunitinib Capsule 50 mg 20 28 3\n- Sunitinib Capsule 50 mg 20 28 5\n- Tafamidis Capsule 61 mg 20 30 5\n- Talazoparib Capsule 100 micrograms (as tosilate) 20 30 5\n- Talazoparib Capsule 250 micrograms (as tosilate) 20 30 5\n- Talazoparib Capsule 350 micrograms (as tosilate) 20 30 5\n- Talazoparib Capsule 500 micrograms (as tosilate) 20 30 5\n- Tamoxifen Tablet 20 mg (as citrate) 20 30 5\n- Tamoxifen Tablet 20 mg (as citrate) 20 60 5\n- Teduglutide Powder for injection 5 mg with diluent 20 28 0\n- Teduglutide Powder for injection 5 mg with diluent 20 28 5\n- Teduglutide Powder for injection 5 mg with diluent 20 28 11\n- Telmisartan Tablet 40 mg 20 28 5\n- Telmisartan Tablet 80 mg 20 28 5\n- Telmisartan with amlodipine Tablet 40 mg-5 mg (as besilate) 20 28 5\n- Telmisartan with amlodipine Tablet 40 mg-10 mg (as besilate) 20 28 5\n- Telmisartan with amlodipine Tablet 80 mg-5 mg (as besilate) 20 28 5\n- Telmisartan with amlodipine Tablet 80 mg-10 mg (as besilate) 20 28 5\n- Telmisartan with hydrochlorothiazide Tablet 40 mg-12.5 mg 20 28 5\n- Telmisartan with hydrochlorothiazide Tablet 80 mg-12.5 mg 20 28 5\n- Telmisartan with hydrochlorothiazide Tablet 80 mg-25 mg 20 28 5\n- Temozolomide Capsule 5 mg 20 5 5\n- Temozolomide Capsule 5 mg 20 15 2\n- Temozolomide Capsule 20 mg 20 5 5\n- Temozolomide Capsule 20 mg 20 15 2\n- Temozolomide Capsule 100 mg 20 5 5\n- Temozolomide Capsule 100 mg 20 15 2\n- Temozolomide Capsule 140 mg 20 5 5\n- Temozolomide Capsule 140 mg 20 15 2\n- Temozolomide Capsule 180 mg 20 5 5\n- Temozolomide Capsule 250 mg 20 5 5\n- Tenofovir alafenamide with emtricitabine, elvitegravir and cobicistat Tablet containing tenofovir alafenamide 10 mg with emtricitabine 200 mg, elvitegravir 150 mg and cobicistat 150 mg 20 60 5\n- Tenofovir with emtricitabine Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg 20 30 2\n- Tenofovir with emtricitabine Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg 20 30 2\n- Terbinafine Tablet 250 mg (as hydrochloride) 20 42 0\n- Terbinafine Tablet 250 mg (as hydrochloride) 20 42 1\n- Teriflunomide Tablet 14 mg 20 28 5\n- Teriparatide Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled cartridge 20 1 5\n- Teriparatide Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen 20 1 5\n- Testosterone I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL 20 1 1\n- Testosterone Transdermal cream 50 mg per mL, 50 mL 20 1 1\n- Testosterone Transdermal gel 50 mg in 5 g sachet, 30 20 1 5\n- Testosterone Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 20 1 4\n- Testosterone Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses 20 1 5\n- Tetrabenazine Tablet 25 mg 20 112 5\n- Theophylline Tablet 200 mg (sustained release) 20 100 5\n- Theophylline Tablet 250 mg (sustained release) 20 100 5\n- Theophylline Tablet 300 mg (sustained release) 20 100 5\n- Tiagabine Tablet 5 mg (as hydrochloride) 20 100 5\n- Tiagabine Tablet 10 mg (as hydrochloride) 20 100 5\n- Tiagabine Tablet 15 mg (as hydrochloride) 20 100 5\n- Ticagrelor Tablet 90 mg 20 56 5\n- Tiotropium Capsule containing powder for oral inhalation 13 micrograms (as bromide) (for use in Zonda device) 20 30 5\n- Tiotropium Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) 20 30 5\n- Tiotropium Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in LupinHaler) 20 30 5\n- Tiotropium Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations) 20 1 5\n- Tiotropium with olodaterol Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses 20 1 5\n- Tocilizumab Injection 162 mg in 0.9 mL single use pre-filled pen 20 4 5\n- Tocilizumab Injection 162 mg in 0.9 mL single use pre-filled pen 20 4 6\n- Tocilizumab Injection 162 mg in 0.9 mL single use pre-filled syringe 20 4 5\n- Tocilizumab Injection 162 mg in 0.9 mL single use pre-filled syringe 20 4 6\n- Tofacitinib Tablet 5 mg 20 56 3\n- Tofacitinib Tablet 5 mg 20 56 5\n- Tofacitinib Tablet 10 mg 20 56 3\n- Tofacitinib Tablet 10 mg 20 56 5\n- Topiramate Capsule 15 mg 20 60 5\n- Topiramate Capsule 25 mg 20 60 5\n- Topiramate Capsule 50 mg 20 60 5\n- Topiramate Tablet 25 mg 20 60 5\n- Topiramate Tablet 50 mg 20 60 5\n- Topiramate Tablet 100 mg 20 60 5\n- Topiramate Tablet 200 mg 20 60 5\n- Trametinib Tablet 500 micrograms 20 90 5\n- Trametinib Tablet 2 mg 20 30 5\n- Trandolapril Capsule 500 micrograms 20 28 5\n- Trandolapril Capsule 1 mg 20 28 5\n- Trandolapril Capsule 2 mg 20 28 5\n- Trandolapril Capsule 4 mg 20 28 5\n- Trandolapril with verapamil Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release) 20 28 5\n- Trandolapril with verapamil Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release) 20 28 5\n- Triamcinolone Injection containing triamcinolone acetonide 10 mg in 1 mL 20 5 0\n- Trientine Capsule containing trientine dihydrochloride 250 mg (equivalent to 166.7 mg trientine) 20 200 5\n- Trihexyphenidyl Tablet containing trihexyphenidyl hydrochloride 2 mg 20 200 2\n- Trihexyphenidyl Tablet containing trihexyphenidyl hydrochloride 5 mg 20 200 1\n- Triptorelin Powder for I.M. injection (prolonged release) 3.75 mg (as embonate) with solvent, syringe and needles 20 1 5\n- Triptorelin Powder for I.M. injection (prolonged release) 11.25 mg (as embonate) with solvent, syringe and needles 20 1 1\n- Triptorelin Powder for I.M. injection (prolonged release) 22.5 mg (as embonate) with solvent, syringe and needles 20 1 0\n- Umeclidinium Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses 20 1 5\n- Umeclidinium with vilanterol Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 20 1 5\n- Upadacitinib Tablet 15 mg 20 28 1\n- Upadacitinib Tablet 15 mg 20 28 3\n- Upadacitinib Tablet 15 mg 20 28 4\n- Upadacitinib Tablet 15 mg 20 28 5\n- Upadacitinib Tablet 30 mg 20 28 1\n- Upadacitinib Tablet 30 mg 20 28 2\n- Upadacitinib Tablet 30 mg 20 28 3\n- Upadacitinib Tablet 30 mg 20 28 4\n- Upadacitinib Tablet 30 mg 20 28 5\n- Upadacitinib Tablet 45 mg 20 28 2\n- Upadacitinib Tablet 45 mg 20 28 3\n- Ustekinumab Injection 45 mg in 0.5 mL 20 1 0\n- Ustekinumab Injection 45 mg in 0.5 mL 20 1 1\n- Ustekinumab Injection 45 mg in 0.5 mL 20 1 2\n- Ustekinumab Injection 45 mg in 0.5 mL 20 2 0\n- Ustekinumab Injection 45 mg in 0.5 mL single use pre-filled syringe 20 1 0\n- Ustekinumab Injection 45 mg in 0.5 mL single use pre-filled syringe 20 1 1\n- Ustekinumab Injection 45 mg in 0.5 mL single use pre-filled syringe 20 1 2\n- Ustekinumab Injection 45 mg in 0.5 mL single use pre-filled syringe 20 2 0\n- Ustekinumab Injection 45 mg in 0.5 mL single use pre-filled syringe 20 2 2\n- Ustekinumab Injection 90 mg in 1 mL single use pre-filled syringe 20 1 0\n- Ustekinumab Injection 90 mg in 1 mL single use pre-filled syringe 20 1 1\n- Ustekinumab Injection 90 mg in 1 mL single use pre-filled syringe 20 1 2\n- Valaciclovir Tablet 500 mg (as hydrochloride) 20 30 5\n- Valproic acid Tablet (enteric coated) containing sodium valproate 200 mg 20 200 2\n- Valproic acid Tablet (enteric coated) containing sodium valproate 500 mg 20 200 2\n- Valsartan Tablet 80 mg 20 28 5\n- Valsartan Tablet 160 mg 20 28 5\n- Valsartan Tablet 320 mg 20 28 5\n- Valsartan with hydrochlorothiazide Tablet 80 mg-12.5 mg 20 28 5\n- Valsartan with hydrochlorothiazide Tablet 160 mg-12.5 mg 20 28 5\n- Valsartan with hydrochlorothiazide Tablet 160 mg-25 mg 20 28 5\n- Valsartan with hydrochlorothiazide Tablet 320 mg-12.5 mg 20 28 5\n- Valsartan with hydrochlorothiazide Tablet 320 mg-25 mg 20 28 5\n- Varenicline Box containing 11 tablets 0.5 mg and 42 tablets 1 mg 20 1 0\n- Varenicline Tablet 1 mg 20 56 2\n- Varenicline Tablet 1 mg 20 112 0\n- Vedolizumab Injection 108 mg in 0.68 mL single use pre-filled pen 20 2 0\n- Vedolizumab Injection 108 mg in 0.68 mL single use pre-filled pen 20 2 5\n- Venetoclax Tablet 100 mg 20 120 2\n- Venetoclax Tablet 100 mg 20 120 4\n- Venetoclax Tablet 100 mg 20 120 5\n- Venlafaxine Capsule (modified release) 75 mg (as hydrochloride) 20 28 5\n- Venlafaxine Capsule (modified release) 150 mg (as hydrochloride) 20 28 5\n- Verapamil Tablet containing verapamil hydrochloride 80 mg 20 100 5\n- Verapamil Tablet containing verapamil hydrochloride 180 mg (sustained release) 20 30 5\n- Verapamil Tablet containing verapamil hydrochloride 240 mg (sustained release) 20 30 5\n- Vigabatrin Oral powder, sachet 500 mg 20 60 5\n- Vigabatrin Tablet 500 mg 20 100 5\n- Vildagliptin Tablet 50 mg 20 60 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 500 mg metformin hydrochloride 20 60 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride 20 60 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride 20 60 5\n- Vismodegib Capsule 150 mg 20 28 3\n- Vosoritide Powder for injection 400 micrograms with diluent 20 30 5\n- Vosoritide Powder for injection 560 micrograms with diluent 20 30 5\n- Vosoritide Powder for injection 1.2 mg with diluent 20 30 5\n- Zanubrutinib Capsule 80 mg 20 120 5\n- Zonisamide Capsule 25 mg 20 56 5\n- Zonisamide Capsule 50 mg 20 56 5\n- Zonisamide Capsule 100 mg 20 112 5\n\n \n\n \n\n \n\n \n\n","sortOrder":8},{"sectionNumber":"Sch 2","sectionType":"schedule","heading":"Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply–increased maximum quantity or number of units","content":"Schedule 2—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply–increased maximum quantity or number of units\n\n \n\n \n\n- Listed drug Form Period(days) Circumstances:\n- Maximum quantity or number of units Maximum number of repeats Other circumstances (if any)\n- Acarbose Tablet 50 mg 50 180 5\n- Acarbose Tablet 100 mg 50 180 5\n- Aclidinium Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses 50 2 5\n- Aclidinium with formoterol Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses 50 2 5\n- Adapalene with benzoyl peroxide Gel 1 mg-25 mg per g, 30 g 50 2 3\n- Alendronic acid Tablet 70 mg (as alendronate sodium) 50 8 5\n- Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol 50 8 5\n- Alendronic acid with colecalciferol Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol 50 8 5\n- Allopurinol Tablet 100 mg 50 400 2\n- Allopurinol Tablet 300 mg 50 120 2\n- Alogliptin Tablet 6.25 mg (as benzoate) 50 56 5\n- Alogliptin Tablet 12.5 mg (as benzoate) 50 56 5\n- Alogliptin Tablet 25 mg (as benzoate) 50 56 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride 50 112 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride 50 112 5\n- Alogliptin with metformin Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride 50 112 5\n- Amantadine Capsule containing amantadine hydrochloride 100 mg 50 200 5\n- Amlodipine Tablet 5 mg (as besilate) 50 60 5\n- Amlodipine Tablet 10 mg (as besilate) 50 60 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with atorvastatin Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) 50 60 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-80 mg 50 56 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-160 mg 50 56 5\n- Amlodipine with valsartan Tablet 5 mg (as besilate)-320 mg 50 56 5\n- Amlodipine with valsartan Tablet 10 mg (as besilate)-160 mg 50 56 5\n- Amlodipine with valsartan Tablet 10 mg (as besilate)-320 mg 50 56 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 5 mg (as besilate)-160 mg-12.5 mg 50 56 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 5 mg (as besilate)-160 mg-25 mg 50 56 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-160 mg-12.5 mg 50 56 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-160 mg-25 mg 50 56 5\n- Amlodipine with valsartan and hydrochlorothiazide Tablet 10 mg (as besilate)-320 mg-25 mg 50 56 5\n- Anastrozole Tablet 1 mg 50 60 5\n- Apixaban Tablet 2.5 mg 50 120 5\n- Apixaban Tablet 5 mg 50 120 5\n- Apomorphine Injection containing apomorphine hydrochloride hemihydrate 50 mg in 5 mL 50 360 5\n- Apomorphine Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 mL 50 180 5\n- Apomorphine Solution for subcutaneous infusion containing apomorphine hydrochloride hemihydrate 50 mg in 10 mL pre-filled syringe 50 360 5\n- Apomorphine Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen 50 200 5\n- Atenolol Oral solution 50 mg in 10 mL, 300 mL 50 2 5\n- Atenolol Tablet 50 mg 50 60 5\n- Atorvastatin Tablet 10 mg (as calcium) 50 60 5\n- Atorvastatin Tablet 20 mg (as calcium) 50 60 5\n- Atorvastatin Tablet 40 mg (as calcium) 50 60 5\n- Atorvastatin Tablet 80 mg (as calcium) 50 60 5\n- Baclofen Tablet 10 mg 50 200 5\n- Baclofen Tablet 25 mg 50 200 5\n- Balsalazide Capsule containing balsalazide sodium 750 mg 50 560 5\n- Beclometasone Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) 50 2 5\n- Beclometasone Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) 50 2 5\n- Beclometasone Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation) 50 2 5\n- Beclometasone Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation) 50 2 5\n- Beclometasone with formoterol Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose 50 2 5\n- Beclometasone with formoterol Pressurised inhalation containing beclometasone dipropionate 200 micrograms and formoterol fumarate dihydrate 6 micrograms per dose, 120 doses 50 2 5\n- Beclometasone with formoterol and glycopyrronium Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses 50 2 5\n- Beclometasone with formoterol and glycopyrronium Pressurised inhalation containing beclometasone dipropionate 200 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses 50 2 5\n- Bimatoprost Eye drops 300 micrograms per mL, 3 mL 50 2 5\n- Bimatoprost Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30 50 2 5\n- Bimatoprost with timolol Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL 50 2 5\n- Bimatoprost with timolol Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 50 2 5\n- Bisacodyl Suppositories 10 mg, 10 50 6 5\n- Bisacodyl Suppositories 10 mg, 12 50 6 4\n- Bisacodyl Tablet 5 mg 50 400 2\n- Bisoprolol Tablet containing bisoprolol fumarate 2.5 mg 50 56 5\n- Bisoprolol Tablet containing bisoprolol fumarate 5 mg 50 56 5\n- Bisoprolol Tablet containing bisoprolol fumarate 10 mg 50 56 5\n- Brimonidine Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL 50 2 5\n- Brimonidine Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL 50 2 5\n- Brimonidine with timolol Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL 50 2 5\n- Brinzolamide Eye drops 10 mg per mL, 5 mL 50 2 5\n- Brinzolamide with brimonidine Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL 50 2 5\n- Brinzolamide with timolol Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL 50 2 5\n- Bromocriptine Tablet 2.5 mg (as mesilate) 50 120 5\n- Budesonide Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 50 2 5\n- Budesonide Nebuliser suspension 1 mg in 2 mL single dose units, 30 50 2 5\n- Budesonide Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses 50 2 5\n- Budesonide Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses 50 2 5\n- Budesonide Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses 50 2 5\n- Budesonide with formoterol Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses 50 2 5\n- Budesonide with formoterol Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 60 doses 50 4 5\n- Budesonide with formoterol Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses 50 2 5\n- Budesonide with formoterol Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses 50 4 5\n- Budesonide with formoterol Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses 50 4 5\n- Budesonide with formoterol Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses 50 4 5\n- Budesonide with glycopyrronium and formoterol Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses 50 2 5\n- Cabergoline Tablet 500 micrograms 50 16 5\n- Cabergoline Tablet 1 mg 50 60 5\n- Cabergoline Tablet 2 mg 50 60 5\n- Calcipotriol with betamethasone Cream containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g 50 2 1\n- Calcipotriol with betamethasone Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g 50 2 1\n- Calcipotriol with betamethasone Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g 50 2 1\n- Calcitriol Capsule 0.25 microgram 50 200 3\n- Calcium Tablet, chewable, 500 mg (as carbonate) 50 480 1\n- Calcium Tablet 600 mg (as carbonate) 50 480 1\n- Candesartan Tablet containing candesartan cilexetil 4 mg 50 60 5\n- Candesartan Tablet containing candesartan cilexetil 8 mg 50 60 5\n- Candesartan Tablet containing candesartan cilexetil 16 mg 50 60 5\n- Candesartan Tablet containing candesartan cilexetil 32 mg 50 60 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg 50 60 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg 50 60 5\n- Candesartan with hydrochlorothiazide Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg 50 60 5\n- Carbamazepine Oral suspension 100 mg per 5 mL, 300 mL 50 2 5\n- Carbamazepine Tablet 100 mg 50 400 2\n- Carbamazepine Tablet 200 mg 50 400 2\n- Carbamazepine Tablet 200 mg (controlled release) 50 400 2\n- Carbamazepine Tablet 400 mg (controlled release) 50 400 2\n- Carbimazole Tablet 5 mg 50 400 2\n- Carbomer Eye gel 2 mg per g, 10 g 50 2 5\n- Carbomer Eye gel 2 mg per g, single dose units 0.6 mL, 30 50 6 5\n- Carmellose Eye drops containing carmellose sodium 5 mg per mL, 10 mL 50 2 5\n- Carvedilol Tablet 6.25 mg 50 120 5\n- Carvedilol Tablet 12.5 mg 50 120 5\n- Carvedilol Tablet 25 mg 50 120 5\n- Chlortalidone Tablet 25 mg 50 200 1\n- Ciclesonide Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation) 50 2 5\n- Ciclesonide Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation) 50 2 5\n- Ciclosporin Capsule 10 mg 50 240 3\n- Ciclosporin Capsule 25 mg 50 120 3\n- Ciclosporin Capsule 50 mg 50 120 3\n- Ciclosporin Capsule 100 mg 50 120 3\n- Ciclosporin Oral liquid 100 mg per mL, 50 mL 50 4 3\n- Citalopram Tablet 10 mg (as hydrobromide) 50 56 2\n- Citalopram Tablet 20 mg (as hydrobromide) 50 56 2\n- Citalopram Tablet 40 mg (as hydrobromide) 50 56 2\n- Clonidine Tablet containing clonidine hydrochloride 100 micrograms 50 200 5\n- Clonidine Tablet containing clonidine hydrochloride 150 micrograms 50 200 5\n- Clopidogrel Tablet 75 mg (as besilate) 50 56 5\n- Clopidogrel Tablet 75 mg (as bisulfate) (Aurobindo, USA) (S19A) 50 56 5\n- Clopidogrel Tablet 75 mg (as bisulfate) (Novadoz, USA) (S19A) 50 56 5\n- Clopidogrel Tablet 75 mg (as hydrogen sulfate) 50 56 5\n- Clopidogrel Tablet 75 mg (as hydrogen sulfate) (S19A) 50 56 5\n- Clopidogrel with aspirin Tablet 75 mg (as hydrogen sulfate)-100 mg 50 60 5\n- Colestyramine Sachets containing 4.7 g oral powder (equivalent to 4 g colestyramine), 50 50 4 5\n- Cortisone Tablet containing cortisone acetate 5 mg 50 100 4\n- Cortisone Tablet containing cortisone acetate 25 mg 50 120 4\n- Cyproterone Tablet containing cyproterone acetate 50 mg 50 40 5\n- Cyproterone Tablet containing cyproterone acetate 50 mg 50 200 5\n- Cyproterone Tablet containing cyproterone acetate 100 mg 50 100 5\n- Dabigatran etexilate Capsule 110 mg (as mesilate) 50 120 5\n- Dabigatran etexilate Capsule 150 mg (as mesilate) 50 120 5\n- Dapagliflozin Tablet 10 mg (as propanediol monohydrate) 50 56 5\n- Dapagliflozin with metformin Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride 50 112 5\n- Dapagliflozin with metformin Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride 50 56 5\n- Dapagliflozin with metformin Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride 50 56 5\n- Dapagliflozin with sitagliptin Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate) 50 56 5\n- Desmopressin Tablet containing desmopressin acetate 200 micrograms 50 60 5\n- Desmopressin Tablet containing desmopressin acetate 200 micrograms 50 180 5\n- Desmopressin Tablet (sublingual) 120 micrograms (as acetate) 50 60 5\n- Desmopressin Tablet (sublingual) 240 micrograms (as acetate) 50 60 5\n- Desmopressin Wafer 120 micrograms (as acetate) 50 60 5\n- Desmopressin Wafer 240 micrograms (as acetate) 50 60 5\n- Desvenlafaxine Tablet (extended release) 50 mg (as succinate) 50 56 2\n- Desvenlafaxine Tablet (extended release) 100 mg (as succinate) 50 56 2\n- Desvenlafaxine Tablet (modified release) 50 mg 50 56 2\n- Desvenlafaxine Tablet (modified release) 50 mg (as benzoate) 50 56 2\n- Desvenlafaxine Tablet (modified release) 100 mg 50 56 2\n- Desvenlafaxine Tablet (modified release) 100 mg (as benzoate) 50 56 2\n- Dexamethasone Tablet 500 micrograms 50 60 4\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg 50 60 5\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg 50 60 5\n- Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg 50 60 5\n- Diltiazem Tablet containing diltiazem hydrochloride 60 mg 50 180 5\n- Dorzolamide Eye drops 20 mg (as hydrochloride) per mL, 5 mL 50 2 5\n- Dorzolamide with timolol Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL 50 2 5\n- Doxycycline Capsule 50 mg (as hyclate) (containing enteric coated pellets) 50 50 2\n- Doxycycline Capsule 100 mg (as hyclate) (containing enteric coated pellets) 50 56 2\n- Doxycycline Tablet 50 mg (as hyclate) 50 50 2\n- Doxycycline Tablet 50 mg (as monohydrate) 50 50 2\n- Doxycycline Tablet 100 mg (as hyclate) 50 56 2\n- Doxycycline Tablet 100 mg (as monohydrate) 50 56 2\n- Duloxetine Capsule 60 mg (as hydrochloride) 50 56 2\n- Dutasteride Capsule 500 micrograms 50 60 5\n- Dutasteride with tamsulosin Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms 50 60 5\n- Empagliflozin Tablet 10 mg 50 60 5\n- Empagliflozin Tablet 25 mg 50 60 5\n- Empagliflozin with linagliptin Tablet containing 10 mg empagliflozin with 5 mg linagliptin 50 60 5\n- Empagliflozin with linagliptin Tablet containing 25 mg empagliflozin with 5 mg linagliptin 50 60 5\n- Empagliflozin with metformin Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride 50 120 5\n- Empagliflozin with metformin Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride 50 120 5\n- Empagliflozin with metformin Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride 50 120 5\n- Empagliflozin with metformin Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride 50 120 5\n- Enalapril Tablet containing enalapril maleate 5 mg 50 60 5\n- Enalapril Tablet containing enalapril maleate 10 mg 50 60 5\n- Enalapril Tablet containing enalapril maleate 20 mg 50 60 5\n- Enalapril with hydrochlorothiazide Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg 50 60 5\n- Entacapone Tablet 200 mg 50 400 4\n- Eplerenone Tablet 25 mg 50 60 5\n- Eplerenone Tablet 50 mg 50 60 5\n- Eprosartan Tablet 600 mg (as mesilate) 50 56 5\n- Eprosartan with hydrochlorothiazide Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide 50 56 5\n- Erythromycin Capsule 250 mg (containing enteric coated pellets) 50 100 2\n- Escitalopram Oral solution 20 mg (as oxalate) per mL, 15 mL 50 2 2\n- Escitalopram Tablet 10 mg (as oxalate) 50 56 2\n- Escitalopram Tablet 20 mg (as oxalate) 50 56 2\n- Esomeprazole Capsule (enteric) 20 mg (as magnesium) 50 60 5\n- Esomeprazole Capsule (enteric) 20 mg (as magnesium) 50 120 5\n- Esomeprazole Capsule (enteric) 40 mg (as magnesium) 50 60 5\n- Esomeprazole Capsule (enteric) 40 mg (as magnesium) 50 120 5\n- Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) 50 60 5\n- Esomeprazole Tablet (enteric coated) 20 mg (as magnesium) 50 120 5\n- Esomeprazole Tablet (enteric coated) 40 mg (as magnesium) 50 60 5\n- Esomeprazole Tablet (enteric coated) 40 mg (as magnesium) 50 120 5\n- Estradiol Pessary (modified release) 10 micrograms (as hemihydrate) 50 36 2\n- Estradiol Tablet 2 mg 50 112 2\n- Estradiol Tablet containing estradiol valerate 1 mg 50 112 2\n- Estradiol Tablet containing estradiol valerate 2 mg 50 112 2\n- Estradiol Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses 50 2 5\n- Estradiol Transdermal gel 500 micrograms in 0.5 g sachet, 28 50 2 5\n- Estradiol Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 50 2 5\n- Estradiol and estradiol with dydrogesterone Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg 50 2 5\n- Estradiol and estradiol with dydrogesterone Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg 50 2 5\n- Estradiol and estradiol with norethisterone Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate 50 2 5\n- Estradiol and estradiol with norethisterone Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate 50 2 5\n- Estradiol with norethisterone Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 50 2 5\n- Estradiol with norethisterone Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 50 2 5\n- Estriol Pessaries 500 micrograms, 15 50 2 2\n- Estriol Vaginal cream 1 mg per g, 15 g 50 2 1\n- Ethosuximide Oral solution 250 mg per 5 mL, 200 mL 50 2 5\n- Everolimus Tablet 0.75 mg 50 240 3\n- Everolimus Tablet 1 mg 50 240 3\n- Exemestane Tablet 25 mg 50 60 5\n- Ezetimibe Tablet 10 mg 50 60 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) 50 2 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) 50 2 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) 50 2 5\n- Ezetimibe and rosuvastatin Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) 50 2 5\n- Ezetimibe with atorvastatin Tablet 10 mg-10 mg 50 60 5\n- Ezetimibe with atorvastatin Tablet 10 mg-20 mg 50 60 5\n- Ezetimibe with atorvastatin Tablet 10 mg-40 mg 50 60 5\n- Ezetimibe with atorvastatin Tablet 10 mg-80 mg 50 60 5\n- Ezetimibe with simvastatin Tablet 10 mg-10 mg 50 60 5\n- Ezetimibe with simvastatin Tablet 10 mg-20 mg 50 60 5\n- Ezetimibe with simvastatin Tablet 10 mg-40 mg 50 60 5\n- Ezetimibe with simvastatin Tablet 10 mg-80 mg 50 60 5\n- Famotidine Tablet 20 mg 50 120 5\n- Famotidine Tablet 40 mg 50 60 5\n- Febuxostat Tablet 80 mg 50 56 5\n- Felodipine Tablet 2.5 mg (extended release) 50 60 5\n- Felodipine Tablet 5 mg (extended release) 50 60 5\n- Felodipine Tablet 10 mg (extended release) 50 60 5\n- Fenofibrate Tablet 48 mg 50 120 5\n- Fenofibrate Tablet 145 mg 50 60 5\n- Fluoxetine Capsule 20 mg (as hydrochloride) 50 56 2\n- Fluoxetine Tablet, dispersible, 20 mg (as hydrochloride) 50 56 2\n- Fluticasone furoate Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses 50 2 5\n- Fluticasone furoate Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses 50 2 5\n- Fluticasone furoate with umeclidinium and vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 50 2 5\n- Fluticasone furoate with umeclidinium and vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 50 2 5\n- Fluticasone furoate with vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 50 2 5\n- Fluticasone furoate with vilanterol Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 50 2 5\n- Fluticasone propionate Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses 50 2 5\n- Fluticasone propionate Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses 50 2 5\n- Fluticasone propionate Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) 50 2 5\n- Fluticasone propionate Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) 50 2 5\n- Fluticasone propionate with formoterol Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses 50 2 5\n- Fluticasone propionate with formoterol Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses 50 2 5\n- Fluticasone propionate with formoterol Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses 50 2 5\n- Fluticasone propionate with salmeterol Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses 50 2 5\n- Fluticasone propionate with salmeterol Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses 50 2 5\n- Fluticasone propionate with salmeterol Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses 50 2 5\n- Fluticasone propionate with salmeterol Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) 50 2 5\n- Fluticasone propionate with salmeterol Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) 50 2 5\n- Fluticasone propionate with salmeterol Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) 50 2 5\n- Fluvastatin Tablet (prolonged release) 80 mg (as sodium) 50 56 5\n- Fluvoxamine Tablet containing fluvoxamine maleate 50 mg 50 60 2\n- Fluvoxamine Tablet containing fluvoxamine maleate 100 mg 50 60 2\n- Formoterol Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) 50 120 5\n- Formoterol Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses 50 2 5\n- Formoterol Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses 50 2 5\n- Furosemide Oral solution 10 mg per mL, 30 mL 50 2 3\n- Furosemide Tablet 20 mg 50 200 1\n- Furosemide Tablet 40 mg 50 200 1\n- Furosemide Tablet 500 mg 50 100 3\n- Gemfibrozil Tablet 600 mg 50 120 5\n- Glibenclamide Tablet 5 mg 50 200 5\n- Gliclazide Tablet 30 mg (modified release) 50 200 5\n- Gliclazide Tablet 60 mg (modified release) 50 120 5\n- Gliclazide Tablet 80 mg 50 200 5\n- Glimepiride Tablet 1 mg 50 60 5\n- Glimepiride Tablet 2 mg 50 60 5\n- Glimepiride Tablet 3 mg 50 60 5\n- Glimepiride Tablet 4 mg 50 60 5\n- Glipizide Tablet 5 mg 50 200 5\n- Glyceryl trinitrate Sublingual spray (pump pack) 400 micrograms per dose, 200 doses 50 2 5\n- Glyceryl trinitrate Transdermal patch 18 mg 50 60 5\n- Glyceryl trinitrate Transdermal patch 25 mg 50 60 5\n- Glyceryl trinitrate Transdermal patch 50 mg 50 60 5\n- Glycopyrronium Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) 50 60 5\n- Hyaluronic acid Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL 50 2 5\n- Hyaluronic acid Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL 50 2 5\n- Hydrochlorothiazide Tablet 25 mg 50 200 1\n- Hydrochlorothiazide with amiloride Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg 50 200 1\n- Hydrocortisone Tablet 4 mg 50 100 4\n- Hydrocortisone Tablet 20 mg 50 120 4\n- Hypromellose 0.3% w/v eye drops, 10 mL (preservative free) 50 2 5\n- Hypromellose Eye drops 3 mg per mL, 10 mL 50 2 5\n- Hypromellose Eye drops 5 mg per mL, 15 mL 50 2 5\n- Hypromellose with dextran Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL 50 2 5\n- Indacaterol Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) 50 60 5\n- Indacaterol Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) 50 60 5\n- Indacaterol with glycopyrronium Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) 50 60 5\n- Indacaterol with glycopyrronium and mometasone Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler) 50 60 5\n- Indacaterol with glycopyrronium and mometasone Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler) 50 60 5\n- Indacaterol with mometasone Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 62.5 micrograms (for use in Breezhaler) 50 60 5\n- Indacaterol with mometasone Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 127.5 micrograms (for use in Breezhaler) 50 60 5\n- Indacaterol with mometasone Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 260 micrograms (for use in Breezhaler) 50 60 5\n- Indapamide Tablet containing indapamide hemihydrate 1.5 mg (sustained release) 50 180 1\n- Indapamide Tablet containing indapamide hemihydrate 2.5 mg 50 180 1\n- Irbesartan Tablet 75 mg 50 60 5\n- Irbesartan Tablet 150 mg 50 60 5\n- Irbesartan Tablet 300 mg 50 60 5\n- Irbesartan with hydrochlorothiazide Tablet 150 mg-12.5 mg 50 60 5\n- Irbesartan with hydrochlorothiazide Tablet 300 mg-12.5 mg 50 60 5\n- Irbesartan with hydrochlorothiazide Tablet 300 mg-25 mg 50 60 5\n- Isosorbide dinitrate Tablet 5 mg (sublingual) 50 400 2\n- Isosorbide mononitrate Tablet 60 mg (sustained release) 50 60 5\n- Isosorbide mononitrate Tablet 120 mg (sustained release) 50 60 5\n- Ivabradine Tablet 5 mg (as hydrochloride) 50 112 5\n- Ivabradine Tablet 7.5 mg (as hydrochloride) 50 112 5\n- Labetalol Tablet containing labetalol hydrochloride 100 mg 50 200 5\n- Lacosamide Oral solution 10 mg per mL, 200 mL 50 4 5\n- Lacosamide Oral solution 10 mg per mL, 200 mL 50 12 5\n- Lacosamide Tablet 50 mg 50 112 5\n- Lacosamide Tablet 100 mg 50 112 5\n- Lacosamide Tablet 150 mg 50 112 5\n- Lacosamide Tablet 200 mg 50 112 5\n- Lamotrigine Tablet 5 mg 50 112 5\n- Lamotrigine Tablet 25 mg 50 112 5\n- Lamotrigine Tablet 50 mg 50 112 5\n- Lamotrigine Tablet 100 mg 50 112 5\n- Lamotrigine Tablet 200 mg 50 112 5\n- Lansoprazole Capsule 15 mg 50 60 5\n- Lansoprazole Capsule 30 mg 50 56 5\n- Lansoprazole Capsule 30 mg 50 112 5\n- Lansoprazole Tablet 15 mg (orally disintegrating) 50 56 5\n- Lansoprazole Tablet 30 mg (orally disintegrating) 50 56 5\n- Lansoprazole Tablet 30 mg (orally disintegrating) 50 112 5\n- Lanthanum Tablet, chewable, 500 mg (as carbonate hydrate) 50 180 5\n- Lanthanum Tablet, chewable, 750 mg (as carbonate hydrate) 50 180 5\n- Lanthanum Tablet, chewable, 1000 mg (as carbonate hydrate) 50 180 5\n- Latanoprost Eye drops 50 micrograms per mL, 2.5 mL 50 2 5\n- Latanoprost with timolol Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL 50 2 5\n- Leflunomide Tablet 10 mg 50 60 5\n- Leflunomide Tablet 20 mg 50 60 5\n- Lercanidipine Tablet containing lercanidipine hydrochloride 10 mg 50 56 5\n- Lercanidipine Tablet containing lercanidipine hydrochloride 20 mg 50 56 5\n- Lercanidipine with enalapril Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg 50 56 5\n- Lercanidipine with enalapril Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg 50 56 5\n- Letrozole Tablet 2.5 mg 50 60 5\n- Levetiracetam Oral solution 100 mg per mL, 300 mL 50 2 5\n- Levetiracetam Tablet 250 mg 50 120 5\n- Levetiracetam Tablet 500 mg 50 120 5\n- Levetiracetam Tablet 1 g 50 120 5\n- Levodopa with benserazide Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release) 50 200 5\n- Levodopa with benserazide Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with benserazide Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) 50 200 5\n- Levodopa with carbidopa Tablet (modified release) 200 mg-50 mg (as monohydrate) 50 200 5\n- Levodopa with carbidopa Tablet 100 mg-25 mg (as monohydrate) 50 200 5\n- Levodopa with carbidopa Tablet 250 mg-25 mg (as monohydrate) 50 200 5\n- Levodopa with carbidopa and entacapone Tablet 50 mg-12.5 mg (as monohydrate)-200 mg 50 400 4\n- Levodopa with carbidopa and entacapone Tablet 75 mg-18.75 mg (as monohydrate)-200 mg 50 400 4\n- Levodopa with carbidopa and entacapone Tablet 100 mg-25 mg (as monohydrate)-200 mg 50 400 4\n- Levodopa with carbidopa and entacapone Tablet 125 mg-31.25 mg (as monohydrate)-200 mg 50 400 4\n- Levodopa with carbidopa and entacapone Tablet 150 mg-37.5 mg (as monohydrate)-200 mg 50 400 4\n- Levodopa with carbidopa and entacapone Tablet 200 mg-50 mg (as monohydrate)-200 mg 50 400 4\n- Linagliptin Tablet 5 mg 50 60 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride 50 120 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride 50 120 5\n- Linagliptin with metformin Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride 50 120 5\n- Liothyronine Tablet containing liothyronine sodium 20 micrograms 50 200 2\n- Lisinopril Tablet 5 mg 50 60 5\n- Lisinopril Tablet 10 mg 50 60 5\n- Lisinopril Tablet 20 mg 50 60 5\n- Macrogol 3350 Powder for oral solution 510 g 50 2 5\n- Macrogol 3350 Sachets containing powder for oral solution 13.125 g with electrolytes, 30 50 2 5\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 5 mg 50 112 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 10 mg 50 60 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 10 mg 50 200 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 100 mg 50 200 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 200 mg 50 120 2\n- Medroxyprogesterone Tablet containing medroxyprogesterone acetate 250 mg 50 120 2\n- Mesalazine Enemas 1 g in 100 mL, 7 50 8 5\n- Mesalazine Enemas 2 g in 60 mL, 7 50 8 5\n- Mesalazine Enemas 4 g in 60 mL, 7 50 8 5\n- Mesalazine Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g 50 8 5\n- Mesalazine Sachet containing granules, 500 mg per sachet 50 400 5\n- Mesalazine Sachet containing granules, 1 g per sachet 50 200 5\n- Mesalazine Sachet containing granules, 1.5 g per sachet 50 120 5\n- Mesalazine Sachet containing granules, 3 g per sachet 50 60 5\n- Mesalazine Sachet containing prolonged release granules, 1 g per sachet 50 200 5\n- Mesalazine Sachet containing prolonged release granules, 2 g per sachet 50 120 5\n- Mesalazine Sachet containing prolonged release granules, 4 g per sachet 50 60 5\n- Mesalazine Suppository (moulded) 1 g 50 60 5\n- Mesalazine Suppository 1 g 50 56 5\n- Mesalazine Tablet 250 mg (enteric coated) 50 200 5\n- Mesalazine Tablet 500 mg (enteric coated) 50 400 5\n- Mesalazine Tablet 500 mg (prolonged release) 50 400 5\n- Mesalazine Tablet 800 mg (enteric coated) 50 180 5\n- Mesalazine Tablet 1 g (enteric coated) 50 240 5\n- Mesalazine Tablet 1 g (prolonged release) 50 240 5\n- Mesalazine Tablet 1.2 g (prolonged release) 50 240 5\n- Mesalazine Tablet 1.6 g (enteric coated) 50 240 4\n- Metformin Tablet containing metformin hydrochloride 500 mg 50 200 5\n- Metformin Tablet containing metformin hydrochloride 850 mg 50 120 5\n- Metformin Tablet containing metformin hydrochloride 1 g 50 180 5\n- Metformin Tablet (extended release) containing metformin hydrochloride 500 mg 50 240 5\n- Metformin Tablet (extended release) containing metformin hydrochloride 1 g 50 120 5\n- Methenamine Tablet containing methenamine hippurate 1 g 50 200 5\n- Methotrexate Injection 50 mg in 2 mL vial 50 10 5\n- Metoprolol Tablet containing metoprolol tartrate 50 mg 50 200 5\n- Metoprolol Tablet containing metoprolol tartrate 100 mg 50 120 5\n- Metoprolol succinate Tablet 47.5 mg (controlled release) 50 60 5\n- Metoprolol succinate Tablet 95 mg (controlled release) 50 60 5\n- Metoprolol succinate Tablet 190 mg (controlled release) 50 60 5\n- Mianserin Tablet containing mianserin hydrochloride 10 mg 50 100 2\n- Mianserin Tablet containing mianserin hydrochloride 20 mg 50 100 2\n- Minocycline Tablet 50 mg (as hydrochloride) 50 120 2\n- Minoxidil Tablet 10 mg 50 200 5\n- Mirtazapine Tablet 15 mg 50 60 2\n- Mirtazapine Tablet 15 mg (orally disintegrating) 50 60 2\n- Mirtazapine Tablet 30 mg 50 60 2\n- Mirtazapine Tablet 30 mg (orally disintegrating) 50 60 2\n- Mirtazapine Tablet 45 mg 50 60 2\n- Mirtazapine Tablet 45 mg (orally disintegrating) 50 60 2\n- Moclobemide Tablet 150 mg 50 120 2\n- Moclobemide Tablet 300 mg 50 120 2\n- Montelukast Tablet, chewable, 4 mg (as sodium) 50 56 5\n- Montelukast Tablet, chewable, 5 mg (as sodium) 50 56 5\n- Moxonidine Tablet 200 micrograms 50 60 5\n- Moxonidine Tablet 400 micrograms 50 60 5\n- Mycophenolic acid Capsule containing mycophenolate mofetil 250 mg 50 600 5\n- Mycophenolic acid Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL 50 2 5\n- Mycophenolic acid Tablet containing mycophenolate mofetil 500 mg 50 300 5\n- Mycophenolic acid Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid 50 240 5\n- Mycophenolic acid Tablet (enteric coated) containing mycophenolate sodium equivalent to 360 mg mycophenolic acid 50 240 5\n- Nebivolol Tablet 1.25 mg (as hydrochloride) 50 112 5\n- Nebivolol Tablet 5 mg (as hydrochloride) 50 56 5\n- Nebivolol Tablet 10 mg (as hydrochloride) 50 56 5\n- Nicorandil Tablets 10 mg, 60 50 2 5\n- Nicorandil Tablets 20 mg, 60 50 2 5\n- Nifedipine Tablet 30 mg (controlled release) 50 60 5\n- Nifedipine Tablet 60 mg (controlled release) 50 60 5\n- Nizatidine Capsule 150 mg 50 120 5\n- Nizatidine Capsule 300 mg 50 60 5\n- Norethisterone Tablet 5 mg 50 60 2\n- Olmesartan Tablet containing olmesartan medoxomil 20 mg 50 60 5\n- Olmesartan Tablet containing olmesartan medoxomil 40 mg 50 60 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) 50 60 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) 50 60 5\n- Olmesartan with amlodipine Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) 50 60 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg 50 60 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg 50 60 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg 50 60 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg 50 60 5\n- Olmesartan with amlodipine and hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg 50 60 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg 50 60 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg 50 60 5\n- Olmesartan with hydrochlorothiazide Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg 50 60 5\n- Omeprazole Capsule 20 mg 50 60 5\n- Omeprazole Capsule 20 mg 50 120 5\n- Omeprazole Tablet 10 mg (as magnesium) 50 60 5\n- Omeprazole Tablet 20 mg 50 60 5\n- Omeprazole Tablet 20 mg 50 120 5\n- Omeprazole Tablet 20 mg (as magnesium) 50 60 5\n- Omeprazole Tablet 20 mg (as magnesium) 50 120 5\n- Opicapone Capsule 50 mg 50 60 5\n- Oxcarbazepine Oral suspension 60 mg per mL, 250 mL 50 4 5\n- Oxcarbazepine Tablet 150 mg 50 200 5\n- Oxcarbazepine Tablet 300 mg 50 200 5\n- Oxcarbazepine Tablet 600 mg 50 200 5\n- Oxybutynin Tablet containing oxybutynin hydrochloride 5 mg 50 200 5\n- Oxybutynin Transdermal patches 36 mg, 8 50 2 5\n- Pancreatic extract Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity 50 1000 10\n- Pancreatic extract Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity 50 400 10\n- Pancreatic extract Capsule (containing enteric coated minimicrospheres) providing not less than 35,000 BP units of lipase activity 50 400 10\n- Pancreatic extract Granules (enteric coated) providing not less than 5,000 BP units of lipase activity per 100 mg, 20 g 50 6 10\n- Pantoprazole Sachet containing granules 40 mg (as sodium sesquihydrate) 50 60 5\n- Pantoprazole Sachet containing granules 40 mg (as sodium sesquihydrate) 50 120 5\n- Pantoprazole Tablet (enteric coated) 20 mg (as sodium sesquihydrate) 50 60 5\n- Pantoprazole Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 50 60 5\n- Pantoprazole Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 50 120 5\n- Paraffin Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer-188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free) 50 2 5\n- Paraffin Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g 50 4 5\n- Paraffin Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g 50 2 5\n- Paroxetine Tablet 20 mg (as hydrochloride) 50 60 2\n- Penicillamine Tablet 125 mg 50 200 1\n- Penicillamine Tablet 250 mg 50 200 1\n- Perampanel Tablet 4 mg (as hemisesquihydrate) 50 56 5\n- Perampanel Tablet 6 mg (as hemisesquihydrate) 50 56 5\n- Perampanel Tablet 8 mg (as hemisesquihydrate) 50 56 5\n- Perampanel Tablet 10 mg (as hemisesquihydrate) 50 56 5\n- Perampanel Tablet 12 mg (as hemisesquihydrate) 50 56 5\n- Perfluorohexyloctane Eye drops, 3 mL 50 2 5\n- Perindopril Tablet containing perindopril arginine 2.5 mg 50 60 5\n- Perindopril Tablet containing perindopril arginine 5 mg 50 60 5\n- Perindopril Tablet containing perindopril arginine 10 mg 50 60 5\n- Perindopril Tablet containing perindopril erbumine 2 mg 50 60 5\n- Perindopril Tablet containing perindopril erbumine 4 mg 50 60 5\n- Perindopril Tablet containing perindopril erbumine 8 mg 50 60 5\n- Perindopril with amlodipine Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) 50 60 5\n- Perindopril with amlodipine Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) 50 60 5\n- Perindopril with amlodipine Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) 50 60 5\n- Perindopril with amlodipine Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) 50 60 5\n- Perindopril with indapamide Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg 50 60 5\n- Perindopril with indapamide Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg 50 60 5\n- Perindopril with indapamide Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg 50 60 5\n- Phenoxymethylpenicillin Capsule 250 mg phenoxymethylpenicillin (as potassium) 50 100 5\n- Phenoxymethylpenicillin Tablet 250 mg phenoxymethylpenicillin (as potassium) 50 100 5\n- Phenytoin Capsule containing phenytoin sodium 30 mg 50 400 2\n- Phenytoin Capsule containing phenytoin sodium 100 mg 50 400 2\n- Phenytoin Oral suspension 30 mg per 5 mL, 500 mL 50 2 3\n- Phenytoin Tablet 50 mg 50 400 2\n- Pilocarpine Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL 50 2 5\n- Pilocarpine Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL 50 2 5\n- Pilocarpine Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL 50 2 5\n- Pioglitazone Tablet 15 mg (as hydrochloride) 50 56 5\n- Pioglitazone Tablet 15 mg (as hydrochloride), pack of 30 50 2 5\n- Pioglitazone Tablet 30 mg (as hydrochloride) 50 56 5\n- Pioglitazone Tablet 30 mg (as hydrochloride), pack of 30 50 2 5\n- Pioglitazone Tablet 45 mg (as hydrochloride) 50 56 5\n- Pioglitazone Tablet 45 mg (as hydrochloride), pack of 30 50 2 5\n- Pizotifen Tablet 500 micrograms (as malate) 50 200 2\n- Polyethylene glycol 400 with propylene glycol Eye drops 4 mg-3 mg per mL, 15 mL 50 2 5\n- Polyethylene glycol 400 with propylene glycol Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28 50 4 5\n- Polyethylene glycol 400 with propylene glycol Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 30 50 4 5\n- Potassium chloride Tablet 600 mg (sustained release) 50 400 1\n- Potassium chloride with potassium bicarbonate Tablet, effervescent, 14 mmol potassium and 8 mmol chloride 50 120 1\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 375 micrograms 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 750 micrograms 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg 50 60 5\n- Pramipexole Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg 50 60 5\n- Pramipexole Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms 50 200 5\n- Pramipexole Tablet containing pramipexole dihydrochloride monohydrate 1 mg 50 200 5\n- Pravastatin Tablet containing pravastatin sodium 10 mg 50 60 5\n- Pravastatin Tablet containing pravastatin sodium 20 mg 50 60 5\n- Pravastatin Tablet containing pravastatin sodium 40 mg 50 60 5\n- Pravastatin Tablet containing pravastatin sodium 80 mg 50 60 5\n- Prazosin Capsule 1 mg (as hydrochloride) (S19A) 50 200 5\n- Prazosin Capsule 2 mg (as hydrochloride) (S19A) 50 200 5\n- Prazosin Tablet 1 mg (as hydrochloride) 50 200 5\n- Prazosin Tablet 2 mg (as hydrochloride) 50 200 5\n- Prazosin Tablet 5 mg (as hydrochloride) 50 200 5\n- Prednisolone Oral solution 5 mg (as sodium phosphate) per mL, 30 mL 50 2 5\n- Prednisolone Tablet 1 mg 50 200 4\n- Prednisolone Tablet 5 mg 50 120 4\n- Prednisone Tablet 1 mg 50 200 4\n- Prednisone Tablet 5 mg 50 120 4\n- Probenecid Tablet 500 mg 50 200 5\n- Progesterone Capsule 100 mg 50 60 5\n- Progesterone and estradiol Pack containing 30 capsules progesterone 100 mg (micronised) and transdermal gel (pump pack) estradiol 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses 50 2 5\n- Propantheline Tablet containing propantheline bromide 15 mg 50 400 5\n- Propranolol Tablet containing propranolol hydrochloride 10 mg 50 200 5\n- Propranolol Tablet containing propranolol hydrochloride 40 mg 50 200 5\n- Propylene glycol Eye drops 60 micrograms per mL, 10 mL 50 2 5\n- Propylthiouracil Tablet 50 mg 50 400 2\n- Pyridostigmine Tablet containing pyridostigmine bromide 10 mg 50 200 5\n- Pyridostigmine Tablet containing pyridostigmine bromide 60 mg 50 300 5\n- Pyridostigmine Tablet containing pyridostigmine bromide 180 mg (modified release) 50 200 5\n- Rabeprazole Tablet containing rabeprazole sodium 10 mg (enteric coated) 50 56 5\n- Rabeprazole Tablet containing rabeprazole sodium 20 mg (enteric coated) 50 60 5\n- Rabeprazole Tablet containing rabeprazole sodium 20 mg (enteric coated) 50 120 5\n- Raloxifene Tablet containing raloxifene hydrochloride 60 mg 50 56 5\n- Ramipril Capsule 1.25 mg 50 60 5\n- Ramipril Capsule 2.5 mg 50 60 5\n- Ramipril Capsule 5 mg 50 60 5\n- Ramipril Capsule 10 mg 50 60 5\n- Ramipril Tablet 1.25 mg 50 60 5\n- Ramipril Tablet 2.5 mg 50 60 5\n- Ramipril Tablet 5 mg 50 60 5\n- Ramipril Tablet 10 mg 50 60 5\n- Ramipril with felodipine Tablet 5 mg-5 mg (modified release) 50 60 5\n- Rasagiline Tablet 1 mg (as mesilate) 50 60 5\n- Reboxetine Tablet 4 mg (as mesilate) 50 120 2\n- Riluzole Oral suspension 50 mg per 10 mL, 300 mL 50 4 5\n- Riluzole Tablet 50 mg 50 112 5\n- Risedronic acid Tablet containing risedronate sodium 5 mg 50 56 5\n- Risedronic acid Tablet containing risedronate sodium 35 mg 50 8 5\n- Risedronic acid Tablet containing risedronate sodium 150 mg 50 2 5\n- Risedronic acid Tablet (enteric coated) containing risedronate sodium 35 mg 50 8 5\n- Rivaroxaban Capsule 15 mg 50 56 5\n- Rivaroxaban Capsule 20 mg 50 56 5\n- Rivaroxaban Tablet 2.5 mg 50 120 5\n- Rivaroxaban Tablet 10 mg 50 60 5\n- Rivaroxaban Tablet 15 mg 50 56 5\n- Rivaroxaban Tablet 20 mg 50 56 5\n- Rosuvastatin Tablet 5 mg (as calcium) 50 60 5\n- Rosuvastatin Tablet 10 mg (as calcium) 50 60 5\n- Rosuvastatin Tablet 20 mg (as calcium) 50 60 5\n- Rosuvastatin Tablet 40 mg (as calcium) 50 60 5\n- Rotigotine Transdermal patch 4.5 mg 50 56 5\n- Rotigotine Transdermal patch 9 mg 50 56 5\n- Rotigotine Transdermal patch 13.5 mg 50 56 5\n- Rotigotine Transdermal patch 18 mg 50 56 5\n- Sacubitril with valsartan Tablet containing sacubitril 24.3 mg with valsartan 25.7 mg 50 112 5\n- Sacubitril with valsartan Tablet containing sacubitril 48.6 mg with valsartan 51.4 mg 50 112 5\n- Sacubitril with valsartan Tablet containing sacubitril 97.2 mg with valsartan 102.8 mg 50 112 5\n- Safinamide Tablet 50 mg 50 60 5\n- Safinamide Tablet 100 mg 50 60 5\n- Salmeterol Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses 50 2 5\n- Saxagliptin Tablet 2.5 mg (as hydrochloride) 50 56 5\n- Saxagliptin Tablet 5 mg (as hydrochloride) 50 56 5\n- Saxagliptin with dapagliflozin Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg 50 56 5\n- Saxagliptin with metformin Tablet (modified release) containing 2.5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride 50 112 5\n- Saxagliptin with metformin Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 500 mg metformin hydrochloride 50 56 5\n- Saxagliptin with metformin Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride 50 56 5\n- Selegiline Tablet containing selegiline hydrochloride 5 mg 50 200 5\n- Semaglutide Solution for injection 2 mg in 3 mL pre-filled pen 50 2 5\n- Semaglutide Solution for injection 4 mg in 3 mL pre-filled pen 50 2 5\n- Sertraline Tablet 50 mg (as hydrochloride) 50 60 2\n- Sertraline Tablet 100 mg (as hydrochloride) 50 60 2\n- Sevelamer Tablet containing sevelamer carbonate 800 mg 50 360 5\n- Sevelamer Tablet containing sevelamer hydrochloride 800 mg 50 360 5\n- Simvastatin Tablet 5 mg 50 60 5\n- Simvastatin Tablet 10 mg 50 60 5\n- Simvastatin Tablet 20 mg 50 60 5\n- Simvastatin Tablet 40 mg 50 60 5\n- Simvastatin Tablet 80 mg 50 60 5\n- Sirolimus Oral solution 1 mg per mL, 60 mL 50 2 3\n- Sirolimus Tablet 0.5 mg 50 200 3\n- Sirolimus Tablet 1 mg 50 200 3\n- Sirolimus Tablet 2 mg 50 200 3\n- Sitagliptin Tablet 25 mg 50 56 5\n- Sitagliptin Tablet 50 mg 50 56 5\n- Sitagliptin Tablet 100 mg 50 56 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 500 mg metformin hydrochloride 50 112 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 850 mg metformin hydrochloride 50 112 5\n- Sitagliptin with metformin Tablet containing 50 mg sitagliptin with 1000 mg metformin hydrochloride 50 112 5\n- Sitagliptin with metformin Tablet (modified release) containing 50 mg sitagliptin with 1000 mg metformin hydrochloride 50 112 5\n- Sitagliptin with metformin Tablet (modified release) containing 100 mg sitagliptin with 1000 mg metformin hydrochloride 50 56 5\n- Sodium acid phosphate Tablet, compound effervescent, equivalent to 500 mg phosphorus 50 200 5\n- Sodium bicarbonate Capsule 840 mg 50 200 2\n- Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 50 4 2\n- Soy lecithin Eye spray 10 mg per mL, 10 mL 50 4 5\n- Spironolactone Tablet 25 mg 50 200 5\n- Spironolactone Tablet 100 mg 50 200 5\n- Sucroferric oxyhydroxide Tablet, chewable, 2.5 g (equivalent to 500 mg iron) 50 180 5\n- Sulfasalazine Tablet 500 mg 50 400 5\n- Sulfasalazine Tablet 500 mg (enteric coated) 50 400 5\n- Sulthiame Tablet 50 mg 50 400 2\n- Sulthiame Tablet 200 mg 50 400 2\n- Tacrolimus Capsule 0.5 mg 50 200 3\n- Tacrolimus Capsule 0.5 mg (once daily prolonged release) 50 60 3\n- Tacrolimus Capsule 0.75 mg 50 200 3\n- Tacrolimus Capsule 1 mg 50 200 3\n- Tacrolimus Capsule 1 mg (once daily prolonged release) 50 120 3\n- Tacrolimus Capsule 2 mg 50 200 3\n- Tacrolimus Capsule 3 mg (once daily prolonged release) 50 100 2\n- Tacrolimus Capsule 5 mg 50 100 3\n- Tacrolimus Capsule 5 mg (once daily prolonged release) 50 60 3\n- Tamoxifen Tablet 20 mg (as citrate) 50 60 5\n- Tamoxifen Tablet 20 mg (as citrate) 50 120 5\n- Telmisartan Tablet 40 mg 50 56 5\n- Telmisartan Tablet 80 mg 50 56 5\n- Telmisartan with amlodipine Tablet 40 mg-5 mg (as besilate) 50 56 5\n- Telmisartan with amlodipine Tablet 40 mg-10 mg (as besilate) 50 56 5\n- Telmisartan with amlodipine Tablet 80 mg-5 mg (as besilate) 50 56 5\n- Telmisartan with amlodipine Tablet 80 mg-10 mg (as besilate) 50 56 5\n- Telmisartan with hydrochlorothiazide Tablet 40 mg-12.5 mg 50 56 5\n- Telmisartan with hydrochlorothiazide Tablet 80 mg-12.5 mg 50 56 5\n- Telmisartan with hydrochlorothiazide Tablet 80 mg-25 mg 50 56 5\n- Teriparatide Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled cartridge 50 2 2\n- Teriparatide Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen 50 2 2\n- Testosterone Transdermal cream 50 mg per mL, 50 mL 50 2 1\n- Testosterone Transdermal gel 50 mg in 5 g sachet, 30 50 2 5\n- Testosterone Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 50 2 4\n- Testosterone Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses 50 2 5\n- Tetrabenazine Tablet 25 mg 50 224 5\n- Thiamine Tablet containing thiamine hydrochloride 100 mg 50 200 2\n- Tiagabine Tablet 5 mg (as hydrochloride) 50 200 5\n- Tiagabine Tablet 10 mg (as hydrochloride) 50 200 5\n- Tiagabine Tablet 15 mg (as hydrochloride) 50 200 5\n- Ticagrelor Tablet 90 mg 50 112 5\n- Timolol Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL 50 2 5\n- Timolol Eye drops 5 mg (as maleate) per mL, 5 mL 50 2 5\n- Tiotropium Capsule containing powder for oral inhalation 13 micrograms (as bromide) (for use in Zonda device) 50 60 5\n- Tiotropium Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) 50 60 5\n- Tiotropium Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in LupinHaler) 50 60 5\n- Tiotropium Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations) 50 2 5\n- Tiotropium Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations), pack of 2 50 1 5\n- Tiotropium with olodaterol Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses 50 2 5\n- Tiotropium with olodaterol Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses, pack of 2 50 1 5\n- Tobramycin Capsule containing powder for oral inhalation 28 mg (for use in podhaler) 50 448 2\n- Tobramycin Solution for inhalation 300 mg in 5 mL 50 112 2\n- Topiramate Capsule 15 mg 50 120 5\n- Topiramate Capsule 25 mg 50 120 5\n- Topiramate Capsule 50 mg 50 120 5\n- Topiramate Tablet 25 mg 50 120 5\n- Topiramate Tablet 50 mg 50 120 5\n- Topiramate Tablet 100 mg 50 120 5\n- Topiramate Tablet 200 mg 50 120 5\n- Toremifene Tablet 60 mg (as citrate) 50 60 5\n- Trandolapril Capsule 500 micrograms 50 56 5\n- Trandolapril Capsule 1 mg 50 56 5\n- Trandolapril Capsule 2 mg 50 56 5\n- Trandolapril Capsule 4 mg 50 56 5\n- Trandolapril with verapamil Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release) 50 56 5\n- Trandolapril with verapamil Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release) 50 56 5\n- Tranylcypromine Tablet 10 mg (as sulfate) 50 100 1\n- Travoprost Eye drops 40 micrograms per mL, 2.5 mL 50 2 5\n- Travoprost with timolol Eye drops 40 micrograms travoprost with timolol 5 mg (as maleate) per mL, 2.5 mL 50 2 5\n- Umeclidinium Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses 50 2 5\n- Umeclidinium with vilanterol Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses 50 2 5\n- Valproic acid Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL 50 4 2\n- Valproic acid Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL 50 4 2\n- Valproic acid Tablet, crushable, containing sodium valproate 100 mg 50 400 2\n- Valproic acid Tablet (enteric coated) containing sodium valproate 200 mg 50 400 2\n- Valproic acid Tablet (enteric coated) containing sodium valproate 500 mg 50 400 2\n- Valsartan Tablet 80 mg 50 56 5\n- Valsartan Tablet 160 mg 50 56 5\n- Valsartan Tablet 320 mg 50 56 5\n- Valsartan with hydrochlorothiazide Tablet 80 mg-12.5 mg 50 56 5\n- Valsartan with hydrochlorothiazide Tablet 160 mg-12.5 mg 50 56 5\n- Valsartan with hydrochlorothiazide Tablet 160 mg-25 mg 50 56 5\n- Valsartan with hydrochlorothiazide Tablet 320 mg-12.5 mg 50 56 5\n- Valsartan with hydrochlorothiazide Tablet 320 mg-25 mg 50 56 5\n- Venlafaxine Capsule (modified release) 75 mg (as hydrochloride) 50 56 2\n- Venlafaxine Capsule (modified release) 150 mg (as hydrochloride) 50 56 2\n- Verapamil Tablet containing verapamil hydrochloride 80 mg 50 200 5\n- Verapamil Tablet containing verapamil hydrochloride 180 mg (sustained release) 50 60 5\n- Verapamil Tablet containing verapamil hydrochloride 240 mg (sustained release) 50 60 5\n- Vigabatrin Oral powder, sachet 500 mg 50 120 5\n- Vigabatrin Tablet 500 mg 50 200 5\n- Vildagliptin Tablet 50 mg 50 120 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 500 mg metformin hydrochloride 50 120 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride 50 120 5\n- Vildagliptin with metformin Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride 50 120 5\n- Zonisamide Capsule 25 mg 50 112 5\n- Zonisamide Capsule 50 mg 50 112 5\n- Zonisamide Capsule 100 mg 50 224 5\n\n \n\n \n\n \n\n","sortOrder":9},{"sectionNumber":"Sch 3","sectionType":"schedule","heading":"Repeals","content":"Schedule 3—Repeals\n\nNational Health (Pharmaceutical benefits–early supply) Instrument 2015\n\n","sortOrder":10},{"sectionNumber":"1","sectionType":"section","heading":"The whole of the instrument","content":"1  The whole of the instrument\n\nRepeal the instrument.\n","sortOrder":11}],"analysis":{"kimi_summary":{"_metrics":{"provider":"moonshot","completionTokens":2953},"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This instrument is a direct replacement of the 2015 Early Supply Instrument (see Schedule 3 repeal). It operates within the specific enabling power of section 84AAA(2) of the *National Health Act 1953*, which authorises the Minister to specify pharmaceutical items and circumstances for early supply. The content remains strictly limited to that purpose: listing medicines and setting supply periods. There is no evidence of scope creep beyond the original legislative intent."},"complexity_factors":["**15 defined terms** in section 5, many of which incorporate definitions from the *National Health Act 1953* (e.g., “pharmaceutical benefit,” “Schedule equivalent,” “listed drug”).","**Extensive cross-referencing** to at least 7 different sections of the parent Act (ss 84, 84AB, 84AAA, 84AJ, 85A, 89A) and to the *National Health (Listing of Pharmaceutical Benefits) Instrument 2024* to interpret “purposes codes” and “relevant purpose.”","**Dual-schedule structure** with divergent rules: Schedule 1 operates on a 20‑day supply model, while Schedule 2 uses a 50‑day model with a fallback to 20 days if specific prior-purpose conditions are not met.","**Conditional logic with nested exceptions**: Section 9 contains a complex formula for calculating the supply period that depends on (a) which schedule applies, (b) whether the previous supply was via prescription or prescriber‑bag, and (c) whether the prior prescription was for a “relevant purpose.”","**Numeric circumstance codes** (0, 1, 2, 3, 4, 5, 6, etc.) listed in the schedules are not defined within this instrument; they require reference to external purpose codes in the Listing Instrument to interpret.","**High-volume tabular data**: The schedules contain over 400 specific pharmaceutical entries (drug name, form, strength, maximum quantity, repeats, and period) that must be matched exactly to apply the correct early‑supply rule."],"plain_english_summary":"This instrument governs when Australians can obtain PBS medicines early — listing which drugs qualify and the permitted early refill periods so patients can avoid gaps in treatment while preventing stockpiling. \n\nIt mainly affects patients needing legitimate early refills, pharmacists who check eligibility and timing, and prescribers who must record appropriate purposes. It preserves PBS affordability and continuity of care while maintaining safeguards against misuse."},"flash_summary":{"complexity_score":8,"scope_assessment":{"changed":false,"description":"The instrument does not change the statutory purpose in the Act; it is a specification under s84AAA(2) of the National Health Act 1953 that lists which PBS pharmaceutical items and circumstances qualify for early supply and sets the applicable early-supply periods. Compared with the prior instrument it updates and enlarges the item lists and, in Schedule 2, sets higher maximum quantities for early supply in certain cases. Those are changes in coverage and operational detail but they sit within the original statutory scope (specifying eligible items, quantities and periods for early supply). The instrument therefore represents an update and operational expansion of the schedules rather than a substantive change of legal scope or a new policy power."},"complexity_factors":["Extensive schedules: Schedule 1 and Schedule 2 together list several hundred individual pharmaceutical-item rows (many hundreds of entries to cross-check).","Two-tier structure: Schedule 1 (standard early-supply rules, includes approved pharmacist supply) vs Schedule 2 (increased maximum quantities but stricter requirement of prescription only) (sections 6–8).","Multiple conditional rules for the applicable period (section 9): different periods depending on Schedule, whether the previous supply was prescription-based, whether the previous supply was for a 'relevant purpose', default 20‑day fallback, and prescriber-bag exception (zero days).","Numerous cross-references: to multiple subsections of the National Health Act 1953 (eg. s84, s84AB, s84AAA, s85A, s89A), and to the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (purposes codes; Schedule 4).","Many defined terms and layered definitions (eg. 'relevant previous supply', 'relevant purpose', 'determined maximum quantity', 'prescriber bag provisions') that require interpretation against other instruments and the Act (Definitions section).","Heterogeneous data columns: each item specifies period(days), maximum quantity or number of units, maximum number of repeats and coded \"other circumstances\", requiring mapping of numeric codes to substantive conditions.","Exceptions and exclusions: e.g., allowed supply by approved pharmacist for Schedule 1 but explicit exclusion for Schedule 2 (section 8(b)); prescriber-bag exception overrides other period rules (section 9(4)).","Operational burden: pharmacists must check prior supply history, prescription purpose and repeats to determine eligibility, creating significant points of potential dispute and record-keeping needs.","Repeal and update mechanics: repeals the 2015 instrument (Schedule 3) and replaces it with a more detailed, expanded schedule, increasing the administrative volume for regulators and stakeholders."],"plain_english_summary":"**What this instrument does (mechanics)\n\n- Names and authorises a delegate to specify which PBS-listed medicines may be supplied early (under subsection 84AAA(2) of the National Health Act 1953) and sets the period of time that must elapse before an \"early\" supply is allowed (see sections 3, 6 and 9).\n\n- Creates two detailed tables (Schedule 1 and Schedule 2) that list particular pharmaceutical items, the form/packaging of each item, the maximum quantity or number of units allowed per prescription, the maximum number of repeats, and the number of days that define the early-supply period for each item (sections 6, 9; Schedules 1–2).\n\n- Distinguishes two categories:\n  - Schedule 1: Items where early supply (and the specified period) applies subject to the circumstances in section 7 — those circumstances allow supply either on a prescription or by an approved pharmacist under subsection 89A of the Act (for example, emergency or pharmacist-initiated supply) (section 7; Schedule 1).\n  - Schedule 2: Items where an increased maximum quantity/units may be supplied for early supply under stricter rules that require the supply to be made on the basis of a prescription (and not under subsection 89A) (section 8; Schedule 2).\n\n- Sets default rules for the period that constitutes an \"early\" supply. For most Schedule 1 items the period is the number of days shown in Schedule 1. For Schedule 2 items the period can be the days shown in Schedule 2 if the most recent previous supply was a prescription for a \"relevant purpose\"; otherwise the default early-supply period is 20 days. If the previous supply was under a \"prescriber bag\" provision the period is zero days (section 9).\n\n- Repeals the prior National Health (Pharmaceutical benefits–early supply) Instrument 2015 (Schedule 3).\n\n\nWho it affects and how (actors & decisions)\n\n- Patients: people taking medicines listed in Schedule 1 or Schedule 2. The instrument changes when those patients are eligible to receive an extra (early) supply of their PBS medicine and, for Schedule 2, may allow a larger quantity at once (Schedules 1–2; section 9).\n\n- Prescribers: must write prescriptions for the listed purpose(s) for the increased/early supply to apply (see definition of \"relevant purpose\" and sections 7–8). If the prescription does not match the purpose(s) specified in the PBS listing, the early-supply rules in these Schedules will generally not apply.\n\n- Pharmacists: must check whether the supply conditions are met (prescription vs approved pharmacist supply under s89A, previous supply details, whether the prescription purpose matches the listing). For Schedule 1 some supplies may be made by an approved pharmacist (s89A); Schedule 2 requires a prescription (sections 7–8).\n\n- Commonwealth (PBS): the Commonwealth subsidy framework is affected because early supply or higher maximum quantities change the timing and size of subsidised dispenses; this can change cashflow and aggregate PBS expenditure (this instrument sets the eligibility rules under s84AAA(2) of the Act).\n\n\nWhy it matters (costs, incentives, trade-offs, implementation points)\n\n- Access vs cost: by specifying more items and by allowing increased maximum quantities for some items (Schedule 2), the instrument makes early supply more widely available to patients. That increases convenience and continuity of therapy for affected patients (who benefit directly) but also increases the potential short‑term cost to the PBS because larger or more frequent subsidised supplies are permitted (Schedules 1–2; section 9).\n\n- Administrative and compliance burden: pharmacies and prescribers must confirm that the prescription purpose and repeat instructions match the PBS listing and the particular Schedule's \"other circumstances\" where applicable. Schedule 2 imposes stricter requirements (prescription only) which requires record checks by pharmacists before early supply (sections 7–8). The instrument cross‑references the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for \"purposes codes\" and \"relevant purpose\", adding a further cross-reference burden.\n\n- Behavioural incentives:\n  - Prescribers: may be required to record or prescribe using the PBS purpose(s) that permit larger supplies to ensure patients can access the increased quantity.\n  - Patients: the option of an earlier or larger subsidised supply may encourage patients to request early fills (including to manage travel, stockouts, or adherence), which can shift timing of PBS claims.\n  - Pharmacies: must verify prior supply history and whether the previous supply was for a \"relevant purpose\" (definition) to determine which early-supply period applies (section 9(3)).\n\n- Substitution and stock risk: allowing larger quantities in a single supply can raise the risk of local shortages or stock management issues, because more product may be dispensed at once to some patients. It may also change private market behaviour (patients choosing PBS-subsidised early supply rather than a private purchase).\n\n- Delegated decision-making and transparency: the instrument is made by a delegate of the Minister under s84AAA(2) of the Act (section 3). The substantive policy judgments about which items and periods apply are implemented through these schedule entries rather than primary legislation; that concentrates operational discretion in administrative instruments which are updated by listing changes.\n\n\nKey technical design points to note (implementation traps)\n\n- Many entries include an \"Other circumstances (if any)\" column coded by numbers. Those numbers should be mapped to the underlying PBS purposes and listing conditions; pharmacists and prescribers need access to the same mapping to interpret the table correctly (Schedules 1–2; Definitions referring to the Listing Instrument 2024).\n\n- The period that defines \"early\" differs by item and is conditional on prior-supply circumstances (section 9): for Schedule 2 items the period shown in the schedule applies only when earlier supply was for a \"relevant purpose\"; otherwise a 20‑day default applies. Separately, if the prior supply was under a prescriber bag the period is zero (section 9(4)).\n\n- Supply under subsection 89A (approved pharmacist supply) is permitted for Schedule 1 items but explicitly excluded for Schedule 2 items (sections 7(a)(ii) and 8(b)). Practically this means pharmacists can sometimes provide an early supply without a new prescription for Schedule 1 items but not for Schedule 2 items.\n\n\nBottom line (practical reading)\n\n- This instrument operationalises early‑supply rules for a very large set of PBS medicines. It tells prescribers, pharmacists and patients (a) which specific medicines are eligible for an early PBS supply, (b) how many units/what maximum quantity may be supplied, (c) how many repeats are allowed, and (d) how many days constitute an \"early\" supply for each listed item. It replaces the 2015 instrument and should be treated as the authoritative schedule for early supply from its commencement date (section 2; Schedule 3).\n\n(Referenced sections: sections 3, 6–9; Schedules 1–3; Definitions cross-referencing the National Health (Listing of Pharmaceutical Benefits) Instrument 2024.)"},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026","history":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026/history","analysis":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026/analysis","conflicts":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026/conflicts","importantCases":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026/important-cases","documents":"/api/acts/national-health-pharmaceutical-benefits-early-supply-specification-2026/documents"}}